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Graft copolymer networks have shown promise as devices for oral delivery of 
proteins. By increasing adhesion of these networks at the delivery site of the upper small 
intestine by utilizing small chemical linkages caused by the novel addition of a synthetic 
or biological functional groups we can make them more viable. The synthetically 
functionalized aldehydes bind covalently by way of a condensation reaction with the 
amines of the amino acids found in the glycoprotein network of the mucus layer of the 
small intestine to form imines. The biologically grafted SlpA protein adhesin from L. 
acidophilus binds to human epithelial cells, mucus and fibronectin. To investigate the 
effectiveness of these bonds, P(MAA-EG) copolymers are prepared with varying 
percentages of grafted aldehyde modified PEG or SlpA protein adhesin and 
characterized. When swollen in buffered solution, results indicate that all formulations 
 xi 
 
with the aldehyde modified PEG or SlpA protein adhesin maintained the desired pH 
sensitivity and transition as those formulations without modification. Bulk adhesion 
testing was carried out through the use of a mechanical testing apparatus for aldehyde 
modified hydrogels in contact with mucus. Adhesion results show an increase to the 
already present adhesion of the copolymers due to increased percentages of the aldehyde 
modified PEG tethers where the highest modified formulation had the largest increase 
over both control formulations. Molecular adhesion testing was performed on the 
aldehyde modified hydrogels utilizing atomic force microscopy as a novel in vitro testing 
method. The new method was developed to gauge the intricacies of adhesion. After, 
using a new technique to build hydrogel capped AFM testing tips, experiments were 
performed with mucus with results indicating an overall increase of adhesion across all 
formulations when compared to bulk tensile testing.  Bulk adhesion testing for the SlpA 
modified hydrogels with Caco-2 cells also showed an increase to the already present 
adhesion of the control copolymers. 
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Chapter 1: Introduction 
 
Using injectable proteins has been an important method of therapy since they first started 
being used in the early part of the 20
th
 century to help those with ailments such as Diabetes 
Mellitus (DM). Numerous research studies have been performed on understanding the various 
ailments and the subsequent protein’s role in combating the diseases. However, there has been 
little headway in administration options for proteins, and to this day, the main course of 
administering proteins is through injection. This is a painful experience patients must endure 
severely limits patient compliance and can cause other severe problems that manifest in ways 
such as blindness and organ failure.  
Patient compliance is a problem for all injectable proteins, such as insulin, calcitonin, 
interferons, and human growth hormone. The lack of compliance with insulin patients alone is of 
great concern due to the 14.6 million people diagnosed with diabetes and an estimated 6.2 
million yet to be diagnosed in the United States alone. With the numbers of those that are taking 
insulin and other injectable proteins growing annually, there is an obvious need for a change in 
administration methods in order to increase patient compliance. Therefore, the development of 
novel oral delivery systems could be the solution to many people’s problems. 
Oral drug delivery has several obstacles that need to be overcome before it is a viable 
solution, such as pH and enzyme conditions that degrade the proteins, and difficulties with the 
transport across the epithelial cell layer. These obstacles and others limit the overall drug 
bioavailability but, the development of novel biomaterials to be used as innovative drug delivery 
devices have started to unlock ways around the problems that are encountered with oral drug 
delivery. The performance of these devices has been improved by synthesizing polymers that 
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have desirable chemical, physical and biological properties and favorable interactions with 
biological materials.  
Recently, the pharmaceutical community has become very interested in the development 
of new and improved muscoadhesive biomaterials with an objective of targeting specific parts of 
the body. This has led to the discovery of new mucoadhesive systems to apply to the nasal, 
buccal, ocular, gastrointestinal, urethral, rectal, and vaginal tissues with the objective of using 
them as delivery devices for therapeutic agents.  
Some of the significant advantages of mucoadhesive drug delivery devices in comparison 
to traditional pharmaceutical dosage forms are that they maintain the drug delivery system in a 
specific location in the body; they have a prolonged duration of contact with the tissue; and they 
increase the treatment efficiency since the drug is locally maintained at the site of action. This is 
important since localizing the drug at a targeted site of absorption and transporting the drug 
across the intestinal epithelial layer are two problems that have previously been discussed with 
low bioavailabilities. This strategy has already been used in many topical treatments and 
improvement has been successfully proven since the early stages of the mucoadhesion field [1-
4]. 
Creating contact between the protein delivery system and the mucosa for an extended 
period is essential and should allow for modulated drug release and increase the absorption of the 
therapeutic agent, resulting in a higher drug bioavailability. One area of research investigates the 
attachment of these mucoadhesive devices to the buccal, nasal, rectal, and vaginal tissues in 
order to avoid any gastrointestinal degradation [5]. In other cases, research has been focused on 
developing a mucoadhesive delivery device for the oral administration of therapeutic agents to 
avoid intravenous therapy [6-8].  
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Approaching the problems previously mentioned by using oral delivery requires the use 
of an intricately designed, novel carrier such as hydrogels. There are numerous applications for 
hydrogels, especially in the medical and pharmaceutical sectors [9-11]. Hydrogels resemble 
natural living tissue because of their high water content and soft consistency similar to that of 
natural tissue[9]. Furthermore, the high water content of the materials contributes to their 
biocompatibility. Thus, hydrogels can be used as contact lenses, membranes for biosensors, 
linings for artificial hearts, materials for artificial skin, and drug delivery devices [9-13].  
Some hydrogels exhibit pH-sensitivity. This renders them suitable candidates for oral 
drug delivery of proteins because of their ability to respond to their environment. We have 
developed hydrogels composed of high molecular weight poly(ethylene glycol) (PEG) grafted on 
poly(methacrylic acid) (PMAA), which will be designated as P(MAA-g-EG). Acrylic-based 
polymers have been extensively used for their mucoadhesive applications since they exhibit very 
high adhesive bond strengths in contact with tissues [14-16]. The mucoadhesive nature should 
give the increased residence time we are looking for and makes them a great selection as the 
desired delivery carrier.  
Adding PEG as a tether can increase the adhesive properties, allowing for 
interpenetration of the polymer chains at the interface, which is important for mucoadhesion. 
When the polymer comes into contact with the mucosa, the concentration gradient at the 
interface provokes the spontaneous diffusion of the polymer chains into the mucus layer and the 
diffusion of the mucin glycoproteins that compose the mucosa into the polymer.  
While these devices have shown promise, improvements must be made before they 
become viable for protein delivery. One possible solution is to incorporate adhesive site specific 
targeting properties into a drug delivery device. There are numerous applications for adhesive 
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site-specific hydrogels, especially in the pharmaceutical sector [9-11]. This site-specific targeting 
can be used to increase adhesion by creating stronger bonds between functional groups of the 
hydrogel and the mucosal and cellular interface than those of secondary and interpenetrative 
forces. Several different functional end groups have already been investigated for their adhesive 
and selective properties. One such group is that of an aldehyde. The aldehyde functional group 
has promise for increasing mucoadhesion through the use of a Schiff base reaction that occurs 
under mild aqueous conditions between aldehydes and amines. In the upper small intestine, the 
aldehyde functional group can be brought into contact with amines found on the glycoprotein 
network of the mucus lining the epithelial cells. This chemical linkage between the two should 
increase the mucoadhesive abilities of the hydrogel [17-19]. The enhanced adhesion is unlikely 
to occur in the stomach because the tethers would be inside of the hydrogel in its complexed 
state. 
Engineering specific mucoadhesive interactions into the carrier is very attractive. Another 
way to pursue this goal will be to use the adhesion mechanism of bacteria in the small intestine. 
Bacterial adhesion to the mucosa is initiated through pili or fimbriae which are cell-surface fibers 
that project an adhesin away from the bacterial surface. Adhesins allow bacteria to adhere to the 
intestinal mucosa through binding to mucosal glycans. Adhesins from nonpathogenic intestinal 
bacteria, such as Lactobacillus acidophilus, could be incorporated into P(MAA-g-EG) hydrogels. 
These adhesins will allow for direct interaction with the mucosa and cellular lining in a manner 
similar to the attachment of bacteria naturally present in the intestine. Choosing to study adhesins 
from the probiotic Lactobacillus should avoid issues with the immunogenicity associated with 
proteins from pathogenic bacteria. Lactobacillus is usually present in the GI tract of most 
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humans and is a probiotic included in many dairy products to boost the immune system and 
gastrointestinal function.  
Overall, the nature of the interaction between the delivery system and mucus layer is not 
yet fully understood. Yet, there have been several in vitro methods put forth to try to gauge this 
interaction in various ways. All of which have some limitation [20, 21]. This complex interaction 
calls for a better understanding of how things take place and interact in all stages of adhesion on 
a molecular level. One way of doing this is by developing an improved model for in vitro testing. 
The use of atomic force microscopy (AFM) could deliver these answers that are needed. 
 AFM has been primarily used for imaging purposes in its short history. AFM can also be 
used as a powerful tool used to investigate and probe the mechanical and viscoelastic properties 
of thin films on the nanoscale [22]. It can measure forces with remarkable sensitivity and 
positional precision called force spectroscopy. Quantitative physical properties can be obtained 
from this data, such as local elasticity, surface forces, surface charge, and hydrophobicity, and to 
measure inter- and intramolecular interactions. This can ultimately provide new insights into the 
molecular bases of processes such as protein folding and receptor–ligand interactions [23, 24]. 
This method would allow for new insight into the molecular interactions between the 
hydrogel and the substrate at each point of adhesion on the molecular level by allowing the 
hydrogel to initiate the interaction and begin bonding before being pulled off to record its 
adhesive nature. These measurements can gauge the affect of the physical and chemical bonds on 
the molecular level which can then be compared on a bulk scale as needed. 
The purpose of this research was to use these new tethers to improve the adhesive 
characteristics of the desired carrier while maintaining the pH sensitivity of the well known 
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mucoadhesive material, PMAA and to gauge these interactions more accurately by developing a 
new in vitro method. 
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Chapter 2: Background 
 
The idea of mucoadhesive drug delivery has had an increase in attention and research in 
the past decade [1]. These delivery systems exploit the attraction between mucus layers and the 
drug polymer carriers. The main advantages of mucoadhesive drug carriers are the localization of 
the carriers within a specific site within the body and prolonged residence time. Both are 
believed to increase the drug bioavailability. Increasing and optimizing these advantages is 
imperative to the future of these delivery systems.  
Here, we first describe the basic concepts of bioadhesion followed by discussing the 
structure of the small intestine from cell layer to mucus layer and its main component, mucin. 
We continue by discussing the multiple theories of mucoadhesion and the synthetic and 
biological forms that have been used to improve adhesion. Finally, we discuss the methods used 
and needed for transmucosal delivery, and methods for determining adhesion. 
2.1 Bioadhesion 
 
The definition of adhesion is when two substances come into molecular contact with one 
another and are held in place, as seen in Figure 2.1.This can also happen due to the presence of a 
third substance between the other two, which acts as an adhesive. Bioadhesion is defined as the 
phenomenon where two materials are held together for extended periods of time by interfacial 
forces with at least one of the materials being biological in nature. When the adhesive attachment 
is to mucus or a mucus membrane, this phenomenon is known as mucoadhesion and cellular 
adhesion when attached to cells [2-10].  
As stated previously, bioadhesion usually consists of a soft tissue or a synthetic material 
that is often used to adhere to another soft tissue. However, bioadhesives have been used 
successfully in hard tissue applications in such areas as orthopedics and dentistry, with some 
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common examples being dental restoration fixatives, skin adhesives, and systems for bacterial 
colonization. Yet, there has recently been more interest in developing more effective 
bioadhesives in other fields such as in tissue engineering [11-13] and also as carriers for drug 
delivery systems [5-10]. Synthetic and natural macromolecules are all materials that have been 
used in bioadhesive applications. These materials can be found on biological components such as 
cell tissue, blood, and bacteria. 
Further understanding of the mechanism of cellular adhesion has been spurred on by the 
desire to create biomimetic materials to aid in developing effective tissue-engineering scaffolds 
as well as biomaterials resistant to biofilm formation. Better cell attachment could be attained 
with the ability to produce synthetic materials that exhibit molecular structures recognized by 
specific cellular components, which would lead to a more favorable response and thus create a 
more biocompatible scaffold [4]. This will be discussed in further detail in a later section. 
Over the last two decades, mucoadhesion has garnered growing interest for its potential 
to improve localized drug delivery. This can be done by retaining a dosage form at the site of 
action such as the small intestine or systemic delivery, or by retaining a formulation in contact 
with the absorption site such as the nasal cavity. Successful mucoadhesive polymers include 
hydrogels. Muco- and bioadhesion of hydrogels is the result of a combination of surface and 
diffusional phenomena that contribute to the formation of adequately strong interchain bridges 
between the polymer and the biological medium [14]. Ultimately, the need to deliver challenging 
molecules such as biopharmaceuticals (proteins and oligonucleotides) has increased interest in 
this field. Mucoadhesive materials could also be used as therapeutic agents to coat and protect 
damaged tissues like gastric ulcers or to act as lubricating agents in the eye or vagina [3]. 
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2.2 Mucins and the Mucosal Layer 
 
Mucus is produced in the ear, nose, and mouth, and also coats the respiratory, 
gastrointestinal, and reproductive tracts [15]. It is important to our bodies for many reasons, but 
primarily for the protection and lubrication of the underlying epithelium. It also serves 
specialized functions; for example, human cervical mucus plays an integral role in both 
conception and contraception. As shown in Figure 2.2, the mucus layer is also the primary site 
with which drug delivery devices interact [8]. Thus, it is essential to understand the structure and 
physical chemistry of mucus if it is to be exploited as a site for bioadhesive controlled drug 
release [16].  
The mucosa in the human stomach has a mean thickness of approximately 190 µm, 
while, in the duodenum, it has a thickness which ranges from 10 to 400 µm [17]. Gastrointestinal 
mucus aids in the passage of food and boluses through the alimentary canal and also helps shield 
the epithelium from shear forces caused by peristaltic waves, and resists autodigestion. These 
characteristics are supported by the constant secretion and replenishment of the mucus due to 
losses from turbulence and degradation. When there is an irritant, such as alcohol or bile salts, or 
a diseased state, several things occur that cause an increase in accelerated mucin release. The 
amount of acidic side chains in the glycoprotein increases from 50% to 80%, resulting in more 
negatively charged mucins. Then, the submucosal gland layer increases in depth and there is an 
increase in the number of goblet cells. There is an increase in the total content of nondialysable 
solids and pH and the mucus is thickened in the GI tract due to DNA and albumin [16]. 
Mucus is a mixture of several components and its composition depends on several things 
such as the type of animal, location, and physiological conditions. The composition of the mucus 
layers is up to 95wt% water, usually from 0.5% to 5wt% mucin, about 1wt% inorganic salts, 
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with the remainder being carbohydrates and lipids [18]. Mucus may be either constantly or 
intermittently secreted [19, 20]. 
Mucin makes up more than 80% of the organic components of mucus [21] and is the 
main factor in controlling its gel-like structure [18]. Electron microscopy results indicate that the 
persistence length of mucin in solution is approximately 100 nm [22] and the effective diameter 
of mucin molecules is around 5 nm. Due to the existence of loops, kinks, and turns, mucin is 
thought to have significant flexibility [15]. Mucins are O-linked glycoproteins [23] directly 
responsible for the gelling properties of mucus and the cohesion properties of the gel. Mucins are 
also block copolymers with branched and unbranched blocks with both types having protein 
backbone chains. However, there is one noticeable difference in that the branched blocks have 
highly branched oligosaccharide chains attached to them. These oligosaccharide branches are 
attached to 63% of the protein core with the remainder of the core consisting of unglycoslyated 
terminal regions [16]. The subunits are coupled by peptide linkages and intramolecular cysteine-
cysteine disulphide bridges.  
In rat goblet cells, mucin exhibits 34 disulphide bridges per molecule while porcine 
intestinal mucin has 28 bridges per molecule, i.e., very similar to the density of disulphide bonds 
in human mucin [16]. The main amino acids in the branched protein blocks are serine, threonine, 
and proline. The serine and threonine residues dominate the amino acid composition, with both 
making up 25–40% of the total amino acids [23]. However, in the non-branched blocks, the 
composition of amino acid is average compared to the strong serine and threonine composition in 
the branched blocks [23] where the branched blocks make up 75% of the length of the protein 
backbone chains [24]. The oligosaccharide branch chains are what make up 50% by weight of 
the mucin [23].  
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At pH > 2.6, the sialic acid and sulphate residues of the branches are fully ionized, 
resulting in a net negative charge to the entire molecule. Since over half of the oligosaccharides 
chains contain acid groups, the charge interactions may have a significant effect on the behavior 
of mucus glycoproteins [16]. Also, it has been shown that the branched and backbone chains are 
charged in appropriate environments, thus increasing the extent of stretched conformation [25]. 
When an aqueous environment is present, the backbone proteins are neutral or hydrophobic; 
however, the branched sugar chains are highly hydrophilic so that if the branched density is high 
and the branched chains are long enough, other molecules only contact the hydrophilic sugar 
chains and not the backbone segments.  
It is important to understand the interactions between mucins and the interactions 
between mucus and polymer. Mucin molecules have both glycosylated hydrophilic and 
unglycosylated hydrophobic peptide blocks which cause the blocks to configure into segregated 
domains. If there is a disruption of the bare peptide blocks by breaking disulfide bridges or by 
peptide proteolytic enzymes, then the gels are no longer able to form and they dissolve into 
aqueous solutions [26]. 
2.3 Intestinal Cell Layer 
 
Under the layer of mucus lies the small intestine. The small intestine is made up of three 
segments, the duodenum, jejunum, and ileum. The first portion, duodenum, is a tube 10 inches in 
length.[27] The next two lengths are the jejunum with the remaining being the ileum. The 
duodenum is the shortest, widest, and where many nutrients are taken into the blood stream.  
The intestinal lining is composed of serous, muscular, areolar, and mucus layers with the 
mucus and areolar being important to drug delivery with most nutrients being transported 
through both and taken into the blood stream. The transport of nutrients occurs because of cell 
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layers, called villi and microvilli, seen in Figure 2.3. The villi and microvilli protrude from the 
mucosal layer and into the open area of the intestine and absorb a majority of the nutrients that 
are present.[27]  
The cell lining is composed of epithelial cells, goblet cells, and endocrine cells which are 
renewed every four to five days. Goblet cells are scattered in rather small numbers but are 
important because of their ability to produce the mucus that creates the mucus lining. They 
secrete mucus essentially continuously but can increase their rate due to increased irritation. 
Endocrine cells are also scattered throughout the small intestine and are used mostly to 
synthesize and secrete the various hormones such as gastrin that aid in the digestive process. 
Epithelial cells compose the majority of the intestinal cell layer. The primary functions of 
epithelial cells are to protect tissue that lies beneath, the regulation and exchange of fluids and 
chemicals, and the secretion of enzymes. The epithelial cells secrete many different types of 
enzymes and proteins such as fibronectin, which is used in cell adhesion and the formation of the 
extracellular matrix.  
Between cells, there is a junctional complex. This layer helps prevent free flow from the 
cells of the lumen to the basal lamina or blood stream side. These tight junctions are important to 
the transport of large molecules that do not have transporters or receptors on the epithelial cells 
surface. They have a series of fusion sites that cause several barriers instead of just one.  
2.4 Oral Delivery Systems 
 
 To date there have been numerous strategies for delivering proteins orally with varying 
levels of success. These strategies can be grouped into three basic categories, modification of 
physiochemical properties, functionalization of macromolecules, and improved carrier systems.  
 There are two main methods for modifying the physiochemical properties. The first 
involves inhibiting enzyme degradation of the protein macromolecule which would thus increase 
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the amount available for absorption. Most common inhibitors such as camostat mesilate, sodium 
glycocholate, and bacitracin have been shown to be effective at increasing the absorption of 
insulin in several studies, however the use of them in long term therapy is in question due to the 
possible absorption of unwanted proteins and increased protease secretion. [28, 29] The second 
method utilizes penetration enhancers to modulate tight junction permeability to increase 
paracellular transport across the cellular membrane. Substances like bile salts and EDTA cause 
the tight junctions to open and allow water soluble proteins, such as insulin, to pass through. The 
drawback is a lack of specificity and can allow unsavory substances such as toxins and 
pathogens to have access to the bloodstream and in some instances can even damage the cell 
membrane. [28, 29] 
 Making chemical modifications allows for increased drug solubility and stability which 
can improve transport across the epithelium. This seems to be more effective for peptides than 
for proteins due to the structural complexity of proteins and can result in loss of pharmacological 
activity. There has been some success with PEGylating insulin. Studies have shown that PheB1-
mPEG-insulin maintain its biological activity and is a viable option to induce a drop in blood 
glucose levels. [30] 
 A most common approach has been to find an improved carrier system that will protect 
the drug from degradation, deliver it to the site of administration, and aid in transport across the 
epithelia. There have been several methods used to try to accomplish this. The pulmonary route 
delivers a dose orally to be absorbed by the large surface area present in the lungs and into the 
bloodstream. Exubera®, an insulin inhaler, was placed on the market but was removed not long 
after due to the limitations and low market share. People who smoked or had lung diseases were 
unable to use the inhaler and the overall bioavailability was inconsistent for those who could use 
it.  
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 Drugs have also been incorporated into liposomes, erythrocytes, and nanospheres for 
delivery. Liposomes are artificial phospholipid membranes produced by naturally occurring 
lipids such as lecithin and cholesterol. This allows the drug to be delivered selectively and can 
protect against unfavorable conditions. Carrier erythrocytes are prepared by separating the 
erythrocytes from plasma. Drugs are inserted inside the erythrocites and they are readministrated. 
The loaded erythrocytes serve as circulation depots, can be surface-modified to improve target 
specificity, and can prevent drug degradation. Nanospheres, or nanoparticles for drug delivery, 
are submicron colloid particles which can be composed of polymers or lipids and can range 
between biodegradable to environmentally responsive. Release usually occurs by diffusion, 
swelling, erosion, or degradation. This form of delivery has several advantages including high 
carrier capacity, can incorporate both hydrophobic and hydrophilic substances, and can be used 
for a sustained release. Each delivery method discussed has had limited success but will require 
further study to increase bioavailability before they become viable. [28, 29] 
 Hydrogels are cross-linked networks that absorb large amounts of water and swell, thus 
resembling natural living tissue and contributing to their biocompatibility. They have many uses, 
but are very favorable for oral delivery of proteins and peptides due to their ability to protect 
drugs from the harsh surroundings of the GI tract and react to their environment. This occurs 
specifically with pH sensitive hydrogels. This type of hydrogel stays complexed at low pH due to 
hydrogen bonding between functional groups. In this state, the drug is protected from the harsh 
conditions of the environment most typically found in the stomach. Upon entering more neutral 
conditions, like those of the small intestine, we see an ionic repulsion causing decomplexation, 
water uptake and swelling of the hydrogel allowing for the release of the drugs. It has also been 
shown that they can increase transport across the intestinal mucosa for improved absorption into 
the bloodstream. There has been limited bioavailability already with acrylic acid based hydrogels 
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but an increase in residence time at the site of absorption through increased adhesion could 
provide the increase needed to become viable. 
2.5 Transmucosal Delivery 
 
Medical science has found treatments for many diseases but the ailments still linger and 
the alleviation of symptoms is the only thing left to be achieved. The emerging practices of 
combinatorial chemistry, along with a growing knowledge of the biochemistry of the human 
body, have led to an ever-increasing number of therapeutic proteins in the treatment of diseases. 
However, these proteins are often not as durable as the more traditional small molecule 
pharmaceutics. Several therapeutic agents, such as aspirin or simple antibiotics, can be orally 
administered with little problem reaching the bloodstream intact, but the larger and more delicate 
proteins must be injected directly into the bloodstream. The stomach prevents this from 
happening with its harsh conditions that destroy a large number of the proteins and prevents 
them from reaching the bloodstream. In the case of insulin, less than 0.1% of the orally 
administered insulin actually reaches the blood stream intact so there is a need for injections 
[31]. This problem demonstrates the need for an alternate route of delivery. One such route is 
oral delivery.  
Oral administration has many barriers with the harsh conditions of the stomach and the 
transport barrier present in the intestines being the most difficult to overcome. The stomach 
contains an acidic environment and many proteolytic enzymes which are the cause of proteins 
being denatured or destroyed in the stomach, rendering them useless. Any proteins that make it 
past these conditions must then somehow be transported across the intestinal epithelium into the 
bloodstream. This process can be hindered even further due to layers of mucus. All of these 
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barriers ultimately lead to a low bioavailability. Thus, it is essential to overcome these barriers 
before oral delivery is even remotely thought of as an alternate route.  
One way of accomplishing this is through developing copolymers that are capable of 
protecting a protein during transit through the stomach and also aiding in increasing the protein’s 
transport across the cellular barrier in the upper small intestine [32].  
The stomach is the main digestive organ of the body and contains many digestive 
enzymes as well as a very low pH. The pH of the stomach has been measured from 1.4 to 2.1 but 
changes to nearly 4.0 when food is present [33]. When proteins are delivered to this harsh 
environment without protection, destruction and denaturation occurs. After the stomach, there is 
the small intestine which has three regions, as stated previously. The amount of nutrients taken 
into the bloodstream decreases the further down the small intestines. The entire length of the 
small intestine is 5 m with a residence time typically ranging from 2 to 4 h. The linings of the 
small intestine are composed of the serous, muscular, areolar, and mucus layers but only the 
mucus and areolar layers are important with respect to drug delivery. The transport of nutrients 
into the body happens through the mucosal layer and into the areolar layer before the nutrients 
are finally transported into the bloodstream. There are cell layers that stick out of the mucosal 
layer and into the open area of the duodenum. These cell layers are where most of the nutrients 
are absorbed into the body [32].  
The transport of nutrients across the cell layer and into the bloodstream can occur through 
any of four different transport mechanisms [34, 35]. The first mechanism, seen in Figure 2.4, is 
transcellular transport and is mainly used for the transport of smaller molecules such as oxygen. 
The molecule diffuses from one side of the barrier, through the cell, and to the other side 
uninhibited since it is either too small or neutral in charge.  
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The second of the four mechanisms of transport is transcytosis. This occurs when 
molecules approach the cellular barrier and interact with the cell membrane. When this happens, 
the membrane forms a pocket of lipid bilayer around the material, which is called a vesicle. The 
vesicle detaches from the cell membrane and passes inside the cell where it is either moved to 
the other side of the cell and released, or digested inside the cell [32]. 
The third mechanism is carrier-mediated transport. This happens when a molecule 
interacts with key groups on the surface of the lipid bilayer. When the molecule comes in contact 
with the bilayer, it reversibly binds to the complexes in it. The bound molecule-complex can then 
cross the lipid bilayer to the inside of the cell. Afterwards, the molecule-complex disassociates 
and moves to the other side of the cell where a similar process occurs that allows the molecule to 
be placed outside of the cell and across the cellular barrier. 
The fourth mechanism of transport is paracellular transport. Paracellular transport occurs 
when the molecules pass through by moving between adjacent cells and is the main route used 
by hydrophilic and charged molecules. The available space and environment between the cells 
dictate the movement. If the area available between the cells was increased, the molecules would 
move easily across the layer. 
Figure 2.5 shows the junctional complex. This complex is the junction between adjacent 
cells, possessed by the cell layer. Without this complex, materials would freely flow between the 
cells from the lumen to the basal lamina or bloodstream side. The junctional complex is divided 
into three regions. The abluminal component is the macula adherens or spot desmosome. The 
second or intermediate region is known as the zonula adherens or intermediate junction. The 
third is the zonula occludens which is the region with the most lumen and is also known as the 
occluding or tight junctions. 
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Tight junctions are needed for transport of large molecules that are without transporters 
or receptors on the epithelial cell’s surface. These junctions consist of a zone between 100–600 
nm in depth where the lateral membranes of adjacent epithelial cells are closely apposed [36]. 
Tight junctions contain a series of fusion sites that create several barriers to flow across the 
epithelium. These tight junctions oppose less flow and are the leakiest in the duodenum but get 
tighter as the small intestine reaches the colon. Thus the duodenum provides an optimal site for 
the release and absorption of proteins 
2.6 Theories of Adhesion 
 
 There have been various attempts to improve the adhesive properties of polymers since 
the concept of mucoadhesion was established many years ago. Several of which include the 
following: using linear poly(ethylene glycol) as an adhesion promoter [37], neutralizing ionic 
polymers [38], using a sustained hydration process for mucoadhesion [39] and developing 
polymer-adhesin conjugates [40, 41] to provide specific binding to the epithelia. The increase in 
adhesion caused by these systems can be attributed to the formation of non-covalent bonds such 
as hydrogen bonds, van der Waals forces, and ionic interactions which are just several of the 
theories of bioadhesion [42].  
There have been numerous theories developed to describe the phenomenon of 
bioadhesion and it is important to understand them all and how they are used to improve 
adhesion. There is no single theory that is widely accepted as the only mechanism for which 
bioadhesion occurs, but rather a combination of theories is used in describing the phenomena. 
The theories are the following: electronic theory, fracture theory, wetting theory, adsorption 
theory, and diffusion theory.  
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The electronic theory states that at the interface between the bioadhesive and the tissue, 
there is a double layer of electrical charge. This is caused by a transfer of electrons upon contact. 
The electron transfer occurs due to the difference in structure between the bioadhesive and the 
glycoprotein chains in the mucus. For this theory, bioadhesion is due to an attraction across the 
electrical double layer [43, 44].  
Through many years of being developed, the adsorption theory has become seen to 
suggest that bioadhesion is due to secondary forces, such as van der Waals forces and hydrogen 
bonding [45]. The fracture theory of bioadhesion relates the force necessary to separate two 
surfaces to the adhesive bond strength [44]. 
The wetting theory, which is associated mostly with liquid bioadhesive systems, 
evaluates a liquid’s ability to spread over a biological surface [46]. Analysis of the spreading 
coefficient of a liquid bioadhesive over a tissue is used to describe the displacement of the 
surrounding gastric fluid. A calculation has been presented to describe the interfacial tension 
between the bioadhesive liquid and the tissue [47]. Afterwards, the interfacial tension was shown 
to be proportional to 
½
, where  is the Flory polymer–polymer interaction parameter. Low 
values of this parameter correspond to structural similarities between polymers and an increased 
miscibility. [48, 49] 
The diffusion theory describes the interpenetration of the polymer chains in the interfacial 
region as seen in Figure 2.6 [50]. In bioadhesion, the polymer is first brought into contact with 
the mucus for an extended period of time. After contact is made, there is a diffusion of the chains 
of the bioadhesive into the mucus layer and also the diffusion of the glycoprotein chains of the 
mucus into the bioadhesive polymer. This diffusion is due to the concentration gradient across 
the interface between the two surfaces. The chemical potential gradient and the diffusion 
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coefficient of a macromolecule through a crosslinked network will determine the diffusion rate. 
The chains that diffuse are used as a form of anchor or tether to semipermanently secure the 
bioadhesive into place. The interpenetration distance needed for good bioadhesion is roughly 
equal to the end-to-end distance of the macromolecular chains [44]. 
2.7 Interdiffusion and Interpenetration  
 
Potential bioadhesives have been evaluated for their adhesive properties, durability, and 
biological inertness [20]. A number of mechanical tests can be used to compare the adhesive 
strength of bioadhesive formulations and can be used in both in vivo and in vitro experiments. 
Previous research found that if free poly(ethylene glycol) (PEG) chains were incorporated, 
mucoadhesion improved significantly [51]. This occurs due to the penetration of the free PEG 
chains across the interface between the mucosa and polymer. This idea was first proposed with a 
study of the adhesion of two similar gels incorporating free PEG chains [37, 52]. Mucoadhesion 
of hydrogels occurs because of a combination of surface and diffusional phenomena. Both of 
these phenomena are contributors to the formation of strong interchain bridges that form between 
the polymer and biological medium [53].  
It is suggested that increasing the chain interpenetration will cause the mucoadhesion to 
be increased. Studies of the mucin interpenetration at the poly(acrylic acid)/mucin interface 
using ATR/FTIR spectroscopy have been completed [54]. The results from this study showed an 
increase in the concentration of mucin inside the poly(acrylic acid) polymer over time. Peppas 
and coworkers have proposed the use of adhesion promoters based on this mechanism to increase 
chain interpenetration and, as a result, mucoadhesion [55-57]. One way of incorporating 
adhesion promoters into the hydrogel is by grafting chains onto the polymer surface. These graft 
chains or tethers have one end chemically attached to the hydrogel surface while leaving the 
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other end free to diffuse and interpenetrate. Once contact occurs, interactions at the interface 
form due to physical entanglements and hydrogen bonds [8]. When the hydrogel is brought into 
intimate contact with the mucus surface, there is diffusion of the tethers across the interface 
caused by the concentration gradient. The loss of chains is prevented by the covalent bond that is 
formed between the tethers and the backbone of the hydrogel structure. The tethers may 
penetrate deep enough into the mucus and act as a bridge between the tissue of the upper small 
intestine and the mucoadhesive device. Figure 2.7 shows a scheme of polymer chains grafted 
onto the backbone of a hydrogel.  
The diffusion at polymer-polymer interfaces has been shown to affect the polymer 
concentration profile and their interfacial thickness [58-61]. There have been multiple techniques 
[62] used to study polymer-polymer interdiffusion such as: neutron and ion scattering X-ray 
fluorescence [63-65], electron microscopy [66-68], Raman and infrared spectroscopy [69-75], 
and light scattering [76, 77]. These studies have been used to show that temperature [78], 
molecular weight [79], molecular weight distribution and composition [80, 81] are important for 
interdiffision at the polymer-polymer interface. These studies also involve the slow mode and 
fast mode theories. These theories indicate that interdiffusion at the polymer-polymer interface is 
controlled by the slower diffusing component when it is below the glass transition temperature. 
However, above the glass transition of the slow diffusing component, the faster diffusing 
component will dictate what takes place [82-86]. 
A theoretical analysis was used to study the interpenetration of free chains in 
mucoadhesion [55-57]. This analysis concluded that the mobility of the diffused chains depends 
on the chain length as well as the gel volume fraction. Free PEG chains were used as adhesion 
promoters with crosslinked poly(2-hydroxethyl methacrylate) particles. These particles resulted 
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in an increase in the mucoadhesive properties of the polymer [51]. This observation was cited as 
being a consequence of the penetration of the free PEG chains across the interface. The idea of 
surface-anchored polymers has also been used in other fields [87, 88]. Gel-gel adhesion by 
tethered polymers has been studied through the use of the single-chain mean-field (SCMF) 
theory with the results providing guidelines for how to design new biomaterials with tethered 
polymer chains [89]. 
The questions involved with using promoters in mucoadhesion can be addressed by 
developing a hydrogel carrier with PEG chain grafts. Copolymer networks of poly(methacrylic 
acid) grafted with poly(ethylene glycol) (henceforth designated as P(MAA-g-EG)) have been 
developed for protein delivery and exhibit reversible, pH-dependent swelling behavior. This 
swelling behavior occurs because of the formation of interpolymer complexes between 
protonated pendant acid groups and the etheric groups on the graft chains. When introduced into 
an acidic surrounding, the complexes form due to protonation of the pendant groups which keep 
the gel from imbibing much fluid. However, when introduced into media where the pH is more 
neutral or basic, the complexes dissociate. This happens because of the ionization of the pendant 
groups, resulting in the gels imbibing water and swelling to a high degree. It is believed that in 
such systems, the free PEG chains that have been grafted onto the gel act as mucoadhesive 
anchors, causing an increase in mucoadhesion and making these carriers very promising as 
systems for protein delivery [53].  
2.8 Synthetic and Biological Forms of Adhesion 
 
One final way to increase adhesion is by creating strong covalent bonds between 
functional groups of the polymer and the mucus and cell layer. This can be accomplished by 
synthetically generating functional end groups or by more biological means by linking the drug 
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delivery vehicle to known adhesive segments found in nature. Several different functional end 
groups have already been investigated for their adhesive and selective properties with more 
garnering increased interest.  
One synthetic group is that of an aldehyde. The aldehyde functional group can increase 
mucoadhesion through the use of a Schiff base covalent reaction in which aldehyde groups 
undergo an acid catalyzed condensation reaction under mild aqueous conditions with amines to 
form a covalent link, giving an imine group with the elimination of water as seen in the reaction 
scheme in Figure 2.8. Even without the elimination of water, the two groups will covalently link 
into an equilibrium state of a hemiaminal through alkylimino-de-oxo-bisubstitution. This will be 
useful in the upper small intestine where the aldehyde can bind with amines found on the 
glycoprotein network of the mucus lining the epithelial cells. [90-92]  
 Adhesive segments found in nature are being studied more and more as scientists try to 
use this information about microorganisms for more beneficial effects in pharmaceutics. This is 
mostly done by determining ways to interrupt adhesion and thus prevent infection. Some are 
looking in a different direction and trying to mimic at least the initial stages of adhesion of these 
microorganisms. Before using these biological options for beneficial purposes it is important to 
understand how microorganisms adhere to materials and subsequently spread. Initial attachement 
for microorganisms depends on the characteristics of the bacterium, the material surface and the 
interface between the two.  
 Just as stated previously in theories of bioadhesion, there are several forces responsible 
for initial attachment including van der Waals, electrostatic and other specific interactions. [93] 
It is also important to be aware of the receptor/binding molecule interactions because they have 
implications with how diseases are spread. This is seen with certain strains of influenza where 
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human-to-human transmission is linked to the binding preferences to certain carbohydrates 
present in the epithelium. [94] To make biomaterials more successful they need to interact with 
the environment more specifically. One critical step in doing this is by achieving successful 
cytoadhesion, which involves cell attachment, cell spreading, and formation of focal adhesions. 
This can be made more effective with ligands that interact specifically with integrins present on 
the cell surface.[95-97] One such approach is with the RGD (Arg-Gly-Asp, Arginine-Glycine-
Aspartic acid) peptide which targets integrin receptors on the cell surface.[97]  
 Heparin-binding peptides and lectins can also be used in cytoadhesion. The peptides 
target proteoglycans while lectins target carbohydrates which are easily found in mucins and cell 
membranes. These have been introduced as ways around the loss of first generation bioadhesives 
that are sloughed off with the mucus and other components present in the GI tract.[98-100] Of 
note is the tomato lectin which has shown an affinity for enterocytes along human Caco-2 cell 
cultures but also reactivity to mucin indicating the binding to the cell surface that is desired may 
be hindered. 
Adhesive drug delivery systems are now evolving to employ segments of fimbriae, long 
filamentous protein projections found on the surface of bacteria, as specific binding moieties. 
[101] These fibers project bacterial lectins, also called adhesins, away from the bacterial surface, 
towards specific glycan receptors on the host cell. In most cases they are found to employ 
adhesins to exploit the diversity and virtually unlimited combinatorial potential of their 
carbohydrate receptors to ensure selective and finely tuned pathogen–host interactions [102]. 
Lactobacillus acidophilus is a probiotic that is part of the bacterial microbiota of the GI 
tract of many humans and animals. It has been used in supplements and milk products and has 
had its genome sequence studied extensively for use in various medicinal purposes. One 
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sequence of paracrystalline protein called surface layer protein A (SlpA) has been discovered to 
be of vital importance in L. acidophilus ability to adhere and colonize human tissue. While the 
mechanism of attachment is still not fully understood, this sequence has been found to be 
adhesive to mucus, epithelial cells, and also parts of the extracellular matrix like fibronectin.  
With more knowledge of the processes involved with the different types of adhesion, 
there can be more effective biomaterials. More effective adhesion will aid in success and 
subsequently result in better treatment and increased quality of life. 
2.9 Methods of Determining Adhesion 
 
Oral drug delivery has had several breakthroughs throughout the last several decades but 
has also been less successful than other delivery methods due to the limits associated with the 
physiology of the gastrointestinal tract. It is important to understand these interactions to 
improve adhesion and thus the efficacy of oral delivery. For this, a large variety of methods for 
evaluating mucoadhesive properties of polymeric materials have been developed over the last 
several decades but there has been little breakthrough in this area of analytical measurements. 
Mucoadhesion is a very complex phenomenon when dealing with the different properties of the 
polymer, tissue, and environment. Overall, the nature of the interaction between the system and 
mucus layer is not yet fully understood. Yet, there have been several in vitro methods put forth to 
try to gauge this interaction in various ways, all of which have some limitation [103, 104]. 
Tensile testing is a staple amongst adhesive testing. Figure 2.9 shows how this method 
gauges the tensile force needed to separate a cylindrical disk from animal mucus, which in turn is 
used to calculate the overall work of adhesion.[105] The falling film technique is a simple 
method where microparticles are placed along a portion of small intestine before having a 
solution poured over it, as seen in Figure 2.10. The eluted particles are determined and are an 
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indication of the mucoadhesive properties.[106] Tensile tests and the trough method give a good 
indicator of this bulk adhesion needed for detachement but have a forced initial interaction not 
seen in the small intestine [107, 108]. 
The flow channel method uses polymer particles placed on a mucus surface. Laminar air 
flow is passed over the particle with photographs taken to analyze the behavior [109]. This 
method doesn’t give quantitative results and results from a forced interaction between particle 
and mucus layer. 
Both the BIACORE™ and mucin particle methods give indications of the affinity that a 
polymer particle has with mucin in the initial stages of attraction but both fail to give any data of 
the strength of the bond formed and thus the ability of the particle to maintain adhesion despite 
various forces that act upon it in the GI tract. 
To develop an optimal carrier for oral protein delivery, a more comprehensive, 
molecular-scale understanding of these complex interactions is necessary. One way of doing this 
is by developing an improved model for in vitro testing.  
Atomic force microscopy (AFM) is a promising technique capable of providing valuable 
information about molecular-scale interactions between tissue and polymeric drug carriers. AFM 
is unique for its ability to provide three-dimensional images of biological structures in ambient 
conditions as well as under physiological conditions with impeccable resolution. Figure 2.11 
shows a diagram of the AFM. The oscillations of the cantilever are reduced and energy lost once 
the probe contacts the surface. This reduction in oscillation as the laser reflects off the cantilever 
and into the photodiode is used to identify and measure features along the surface of the 
substrate. [110, 111] 
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While AFM has predominantly been used as an imaging tool, the method lends itself to 
molecular adhesion measurements. These measurements can gauge the affect of the physical and 
chemical bonds on the molecular level which can then be compared on a bulk scale as needed. 
Other works have used AFM in this fashion while modifying AFM probes to measure the 
adhesion characteristics of substrates such as living cells. However, these modified tips are 
chemically made with small covalently bonded molecules as opposed to larger crosslinked 
particles.[112]  
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Figure 2.1.The sketch shows bioadhesion with molecular contact (adherence) of two 
tissues through the application of a bioadhesive between the two surfaces. 
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Figure 2.2. The sketch shows bioadhesion with molecular contact (adherence) of two 
tissues through the application of a bioadhesive between the two surfaces. 
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Figure 2.3. Picture of villi and microvilli present in the small intestine [113]  
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Figure 2.4. This sketch shows the four mechanisms of transport across a cell 
monolayer. The first is paracellular transport. Next is transcellular transport. Third 
is carrier-mediated transport, and the last is endo/transcytosis transport. 
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Figure 2.5. This sketch shows the environment and components of the upper small 
intestine. 
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Figure 2.6. Upon contact, the interface between two polymer systems disappears and 
chain interpenetration or diffusion occurs. The sketch shows the interdiffusion of 
polymer chains in adhesion. (A) Top polymer layer and bottom layer before contact; 
(B) right after contact; (C) the interface becomes diffuse after contact for a period of 
time. 
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Figure 2.7. The sketch is a representation of polymer chains incorporated in 
hydrogel matrices as adhesion promoters. The polymer chains (red) are grafted onto 
the hydrogel backbone (black). 
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Figure 2.8. Chemical formula showing the chemical reaction between an aldehyde 
and an amine to form a Schiff base. [114]  
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Figure 2.9. Representation of an Instron tensile testing apparatus with a hydrogel 
sample on the upper clamp and mucus on the lower clamp. 
  
 Figure 2.10. Picture of the trough adhesion test.
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Figure 2.11. Diagram of how an AFM works.
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Chapter 3: Research Objectives 
 
The purpose of this research was twofold: first, to improve upon an already 
established oral delivery vehicle by improving the system’s adhesive characteristics while 
maintaining its pH sensitivity and second, to improve upon conventional in vitro adhesive 
testing and protocols. In this research, we use both synthetic and biological types of 
tethers grafted onto the poly(methacrylic acid) (PMAA) hydrogel with additional 
polyethylene glycol (PEG) grafts. This system has been designated as P(MAA-g-EG).  
Acrylic-based polymers have been extensively used for mucoadhesive 
applications since they exhibit very high adhesive bond strengths in contact with tissues, 
increasing residence time and drug bioavailability in most cases. Adding PEG as a tether 
and other modified tethers can increase the adhesive properties, allowing for 
interpenetration of the polymer chains at the interface and in the case of the modified 
tethers create stronger covalent bonds to the tissue. 
I hypothesize that better adhesion can be achieved with these modified tethers by 
creating stronger bonds to the mucus and epithelium of the small intestine. The first 
tether includes an aldehyde end group synthetically modified to the already grafted PEG 
tethers. This tether will bind to the amines found in the glycoprotein network of the 
mucus layer. The second tether links a purified adhesive protein found in the benign 
intestinal bacteria Lactobacillus acidopholus to the P(MAA-g-EG) hydrogel. This protein 
has been shown to be responsible for the attachment of the bacteria to the epithelium of 
the intestinal wall. I further hypothesize that atomic force microscopy can be utilized to 
give a better-defined adhesive profile of the hydrogels versus conventionally accepted in 
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vitro experimentation. The following chapters indicate that experiments I performed and 
the results obtained to verify my hypothesis. 
Chapter 4 describes synthesis and characterization of the aldehyde modified PEG 
tethered hydrogels. The objective was to examine if the addition of the synthetic 
functional group increases the mucoadhesion of the methacrylic hydrogels while 
maintaining the desired characteristics. The amount of aldehyde modified PEG tethers 
was varied with unmodified PEG to investigate these parameters.  
Chapter 5 describes the characterization and subsequent protocols for in vitro 
adhesion testing through force plot analysis with an atomic force microscope. The 
objective was to investigate a new method for in vitro adhesion testing that will avoid the 
limitations seen in most other accepted techniques. This new testing procedure was 
compared against a more established method using hydrogels developed in chapter 4. 
Chapter 6 describes the synthesis and characterization of the L. acidophilus 
derived SlpA bacterial protein tagged hydrogel microparticles. The objective was to 
examine if the addition of the biologically derived protein adhesin increases the cellular 
adhesion of the methacrylic hydrogels while maintaining the desired characteristics.  
Chapter 7 presents conclusions based on the previous chapters’ results and 
recommendations for future work. 
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Chapter 4: Synthesis and Properties of Poly(Methacrylic Acid) pH 
Sensitive Hydrogels with Aldehyde Modified PEG Tethers 
Introduction 
 
Administration of proteins has been an important unsolved problem of drug 
delivery. While scientists race to discover better treatments for the diseases that plague 
societies throughout the world, administration of many of these treatments pose problems 
that can be quite severe. Many who need specific proteins to help with their afflictions 
must take multiple injections daily. Many are unwilling to go through this ordeal and 
those who do still see other side effects. Oral delivery of proteins, such as insulin for 
diabetics would prove to be convenient, improve patient compliance, and have better 
mimicry of dosage into the portal vein.[1] However, oral delivery has several obstacles 
that need to be overcome before it is a viable solution. These problems range from 
enzymes that digest the proteins to difficulties with the transport of large molecules 
across the mucosa and epithelial cell layer. These obstacles limit the overall drug 
bioavailability to ranges that are not commercially acceptable. However, contributions by 
pharmaceutical and biomaterials scientists have led to the development of novel carriers 
to be used as innovative drug delivery systems. The performance of these systems was 
improved by synthesizing polymers that have desirable chemical, physical, and biological 
properties and favorable interactions with biological materials. These advancements have 
started to unlock ways around the problems that are encountered with oral drug 
delivery.[2-6] 
Incorporating mucoadhesive properties into a drug delivery system has many 
significant advantages compared to traditional pharmaceutical dosage forms. The 
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mucoadhesive properties can maintain the drug delivery system in a specific location in 
the body, have a prolonged duration of contact with the tissue, and increase the treatment 
efficiency since the drug is locally maintained at the site of transport. This is important 
since localizing the drug at a targeted site of absorption and transporting the drug across 
the intestinal epithelial layer are two problems associated with the low bioavailabilities 
that often plague oral protein delivery. Increased contact of the drug delivery system with 
the mucosal absorptive membranes for an extended period could increase the absorption 
of the therapeutic agent, resulting in a higher drug bioavailability. This strategy is already 
used in many topical treatments, and improvement was successfully proven since the 
early stages of the mucoadhesion field.[2-6] 
Hydrogels with pH-sensitivity make excellent candidates for the oral delivery 
route because of their ability to respond to their environment, they resemble natural living 
tissue, are biocompatible, and provide the protection of proteins needed in harsh 
environments.[7-11] Hydrogels composed of high molecular weight poly(ethylene 
glycol) (PEG) grafted on  poly(methacrylic acid) (PMAA), which will be designated 
P(MAA-g-EG), have been made and investigated. Briefly, the hydrogels swelling 
behavior occurs because of the formation of interpolymer complexes between protonated 
pendant acid groups and the etheric groups on the graft chains. This interpolymer 
complexation is a thermodynamically favorable event and is reversible.[12, 13] Acrylic-
based polymers have been extensively used for mucoadhesive applications because they 
exhibit high adhesive bond strengths in contact with tissues.[14-16] This increases 
residence time and drug bioavailability in most cases. Researchers believe that in such 
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systems, the free PEG chains that were grafted onto the gel act as mucoadhesive anchors, 
causing an increase in mucoadhesion and making these carriers very promising as 
systems for protein delivery.[17] 
One way to increase adhesion is through creating stronger bonds between 
functional groups. Several different functional end groups have already been investigated 
for their adhesive and selective properties with more garnering increased interest. One 
such group is that of an aldehyde. The aldehyde functional group has promise for 
increasing mucoadhesion through the use of a Schiff base covalent reaction in which 
aldehyde groups undergo an acid-catalyzed condensation reaction under mild aqueous 
conditions with amines to form a covalent link, giving an imine group with the 
elimination of water. Even without the elimination of water, the two groups will 
covalently link into an equilibrium state of a hemiaminal through alkylimino-de-oxo-
bisubstitution. In the upper small intestine, the aldehyde functional group can be brought 
into contact with amines found on the glycoprotein network of the mucus lining the 
epithelial cells. This chemical linkage between the two should increase the mucoadhesive 
abilities of the hydrogel yet still be discharged from the body when the mucus layer of the 
small intestines is renewed every six hours.[18-20] These interactions should be 
prevented in the stomach because the tethers should be inside of the hydrogel in its 
complexed state. 
In this research, we propose the use of aldehyde modified PEG tethers for 
improved adhesion to the upper small intestine to address the barriers that should 
ultimately lead to meeting the ultimate goal of improved bioavailability.  
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Materials and Methods 
Synthesis of Aldehyde Modified PEG 
 
 PEG aldehyde was synthesized by a reaction outlined by Dr. Steven Ley.[21] 
Briefly, PEG monomethacrylate monohydroxyl (PEGMA, Sigma, St. Louis, MO) was 
dissolved with Dichloromethane (DCM, Sigma, St. Louis, MO), 4 angstrom sieves 
(Sigma, St. Louis, MO), and N-methyl morpholine N-oxide (NMO, Sigma, St. Louis, 
MO). The solution was purged with N2 for 10 minutes and the catalyst, tetra-n-
propylammonium per-ruthenate (TPAP, Sigma, St. Louis, MO), was added. Following 
this step, the solution was purged for an additional 10 minutes with N2. The solution was 
stirred for 30 minutes until a change from dark green to black was observed, indicating 
the reaction was successful.[21] After mixing, DCM was added before several salt 
washes were performed (potassium chloride, copper (II) sulfate, sodium sulfate) in a 
separatory funnel. The remaining organic layer was dried over several days to remove 
any remaining solvents. A Schiff’s base assay composed of fuchsin sulfurous acid 
(Sigma, St. Louis, MO) was used to detect aldehydes on a UV/VIS spectrometer. A 
standards curve was made using glutaraldehyde (Sigma, St. Louis, MO) and the Schiff’s 
base assay. Figure 4.1 shows the structure of aldehyde modified PEGMA. 
Hydrogel Synthesis 
 
The methacrylic acid (MAA) monomer was passed through a dehibit column to 
remove the inhibitor. The polymer films were prepared by free radical UV 
polymerization. The diluted monomer mixture was composed of methacrylic acid (MAA, 
Sigma, St. Louis, MO) and both PEGMA and aldehyde modified PEGMA with a 
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molecular weight of approximately 500. Irgacure® 184 (1-hydroxy-cyclohexyl-
phenylketone, Ciba-Geigy, Hawthorne, NY), which was used as a photoinitiator, and 
tetraethylene glycol dimethacrylate (TEGDMA, Polysciences Inc. Warrington, PA), 
which was used as a crosslinking agent was also incorporated. Deionized water and 
ethanol were used as solvents. The monomer solution was made in a ratio of 1:1, 
MAA:EG units, with three formulations containing aldehyde modified PEGMA in 
percentages of 0.06%, 0.6%, and 3.3%, incorporated with unmodified PEGMA as well as 
solutions of P(MAA) with no PEG tethers and P(MAA-EG) with no aldehyde modified 
PEGMA. TEGDMA was added as 1 mol% of the total monomer and Irgacure® 184 
added as 1 wt% of the total monomer.  
The monomer solution was dissolved with a 50:50 monomer to solvent weight 
ratio. The total solvent weight was composed of equal parts deionized water and ethanol. 
Once all components were added to the monomer mixture, the solution was sonicated 
until all materials were dissolved into solution. The mixture was purged with nitrogen for 
20 minutes to remove oxygen, which acts as a free radical scavenger. The solution was 
pipetted between two glass slides (75mm X 50mm X 1mm) separated by a 0.8 mm 
Teflon® spacer. The slides were placed under a UV light (Efos Corporation, Ultracure 
100ss, high pressure mercury lamp, Mississauga, Ontario, Canada) and allowed to 
polymerize for 30 minutes.  
After polymerization was complete, the thin films were washed with deionized 
water daily for one to two weeks to remove all unreacted components. After washing, the 
films were cut into 12mm diameter disks and dried under a vacuum (Heraeus VTR-
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5036, Heraeus Instruments GmbH., Hanau, Germany) for two days at approximately 30° 
C. Fourier transform infrared spectroscopy (FTIR) was used to determine if the Schiff’s 
linkage was still taking place in the hydrogels with aldehyde modified PEGMA. 
Swelling Analysis 
 
Dynamic swelling studies were performed using dimethylglutaric acid (DMGA, 
I=0.1M, Acros Organics, NJ) buffers. Ten buffers, with a pH range of 3.2 to 7.6 were 
prepared. The ionic strength of the buffers was controlled with 0.1M sodium chloride 
(NaCl, Sigma Aldrich, St. Louis, MO). The polymer disks were placed in 50 mL of the 
first DMGA buffer with a pH of 3.2 for five minutes at 37° C. Afterward, the disks were 
taken out of the buffer, blotted to remove excess buffer, and weighed to determine the 
water uptake. The disks were then placed in the DMGA buffer of the next highest pH and 
the process was repeated up to the buffer with a pH of 7.6.  
For equilibrium swelling, polymer disks were swollen in five different pH 
solutions for a span of 48 hours at 37° C. One disk was placed in each of the five 
different DMGA buffers with a pH range between 3.2 and 7.6. Afterward, the swollen 
disks were blotted to remove excess buffer and weighed in ambient air to determine the 
water uptake. 
The following equation was used to determine the weight swelling ratio, Q:  
Q= Wswollen/ Wdry           (1) 
Wswollen and Wdry refer to the weights of the copolymer disk in swollen and dry 
states, respectively. These values were then used to plot weight swelling ratio, Q, vs. 
swelling pH. 
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Insulin Loading and Release Analysis 
 
Hydrogel films were dried, crushed, and sieved with a mesh size of 45µm. Images 
of particles were taken on a light microscope and processed using an image processing 
program. Particle size distribution was found to be 8.5 mm with a standard deviation of 
5.8mm. All glassware was treated with Sigmacote® (Sigma Aldrich, St. Louis, MO) to 
prevent insulin adsorption on the glass wall. Approximately, 140 mg of crushed hydrogel 
particles were dispersed into 20 ml of human insulin solution (500 µg/mL in phosphate 
buffered saline (PBS) at pH = 7.4) at 37° C and stirred for four hours. Afterwards, 10 ml 
of 0.1M hydrochloric acid (HCl, Sigma Aldrich, St. Louis, MO) was added to the 
solutions to collapse the hydrogel network. The particles were filtered and rinsed with 50 
ml of 0.1 M HCl and 50 ml of DI-water to remove any surface bound protein. The loaded 
particles were then lyophilized.  
The concentration of insulin in the loading filtrate was determined by reverse 
phase high performance liquid chromatography (RP-HPLC). The amount of insulin 
loaded was based on the amount of insulin remaining in the loading filtrate to the initial 
insulin in the loading solution. Briefly, aliquots of 0.2 ml of the loading filtrate were 
taken using a 1 ml syringe with a 0.45 µm filter. The mobile phase for the RP-HPLC was 
composed of a mixture of mobile phase A [water with 0.1% TFA (v/v)] and mobile phase 
B [acetonitrile with 0.1% TFA (v/v)] on a Waters Symmetry300™ C18 column (5 µm, 
3.9 x 150 mm). Samples of 20 µl were injected to Waters 2695 separations module 
equipped with a 996 Photodiode Array detector (Milford, MA) at 1 ml/min. A gradient 
from 25-38% mobile phase B was run for 10 minutes. Concentrations were determined 
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based on the area under the curve compared to insulin standards with detection at 254 
nm. 
Release studies using the insulin loaded polymer (ILP) were performed by adding 
15 mg of the ILP to 30 ml of PBS at pH = 7.4 into a Distek Dissolution System 2100B 
(New Brunswick, NJ). The solutions were stirred with 0.8 ml aliquots withdrawn using a 
syringe equipped with a 0.45 µm syringe filter at time intervals of 10, 30, 60, 90, 180, 
360, and 1440 minutes. A constant release volume was maintained by addition of 0.8 ml 
of fresh PBS. These studies were done in triplicate. The protein concentrations for the 
release time points were determined using a Micro BCA™ Protein Assay Kit (Thermo 
Scientific, Rockford, IL), measured by a microplate reader at 570 nm. 
Adhesion Analysis 
 
The adhesion of the polymers in contact with mucin was measured with a 
mechanical testing apparatus (Instron 4442, 50 N load cell, Canton, MA). The hydrogels 
were swollen for 10 minutes in a PBS solution (pH 7.4) and fixed to the upper support 
with cyanoacrylate medical adhesive. One milliliter of 2 wt% porcine mucin (Sigma 
Aldrich, St. Louis, MO) in DI water was deposited on the lower mount of the tensile 
tester. The 2 wt% was chosen to mimic the mucin percentage found in the small intestine. 
The two surfaces were brought into contact with an impingement force of approximately 
0.05N-0.1N. The upper clamp was raised at a constant rate of 6 mm/min until complete 
detachment occurred while the detachment force (N) vs. displacement (m) was measured. 
The work of adhesion (µJ) was taken to be the area under the curve. This procedure was 
also performed in an aqueous environment with 10ml of PBS buffer (pH 7.4) in ambient 
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conditions, which is to say at room temperature and open to the atmosphere. To prevent 
dissolution in the PBS buffer, the mucin solution was made at 20 wt%. The added 10 ml 
of PBS bringing the overall solution back to 2 wt% of mucin solution. 
Results 
Analysis of Chemical Structure 
 
 FTIR spectroscopy was performed to investigate the functionality of the aldehyde 
modified PEGMA after polymerization to the pH sensitive hydrogel. Spectra were taken 
of the Schiff’s reagent, a dry sample of the 3.3% aldehyde modified PEGMA 
formulation, and a 3.3% aldehyde modified PEGMA formulation soaked in Schiff’s 
reagent and washed in DI water to remove excess unreacted Schiff’s reagent as seen in 
Figure 4.2a and b. 
Figure 4.2a shows a broad peak between 3000-3500 (cm-1) for the Schiff’s 
reagent spectra. This broad peak distinguishes the amine and aromatic groups found in 
the fuchsin sulfurous acid of the Schiff’s reagent, which is noticeably absent from the 
dried 3.3% sample but is evident in the soaked and washed 3.3% sample. This indicates 
that the aldehyde bound to the Schiff’s reagent since there are no aromatics or amines 
present in the initial hydrogel sample. 
In the washed 3.3% sample of Figure 4.2b there are two distinct peaks at 
1175(cm-1) and 1300 (cm-1) that are absent in the dried 3.3% sample. These two peaks 
are shifted due to the steric hindrance with such large molecules but indicate the presence 
of sulfurous acid. These double peaks indicate that the aldehyde is bound to the Schiff’s 
reagent since there is no sulfurous acid present in the initial hydrogel sample. The 
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aldehyde modified PEGMA polymerized to the hydrogel and maintained functionality 
throughout the polymerization process. 
This study allows us to confirm that the aldehyde modified PEG tethers are still 
functional. This indicates that they survived the harsh conditions of the polymerization 
process and remain active to be utilized in the adhesion to the gastrointestinal tract.  
Hydrogel Swelling 
 
 It is important to understand the phenomenon of complexation through hydrogen 
bonding. Interpolymer complexation forms between electron deficient moieties and 
moieties containing regions of high electron density. This interpolymer complexation is a 
thermodynamically favorable event and is reversible. In acidic surroundings, the 
copolymer is in a collapsed state because of the hydrogen bonding between the ether 
group of the PEG chain and the carboxylic group of the PMAA.[12, 13] The pH must be 
sufficiently below the pKa to allow for sufficient protonation of the carboxylic acids 
group. As the pH values reach the pKa value of MAA (4.8), the carboxylic acids are 
ionized. This ionization causes the dissociation of the hydrogen bonds, resulting in a 
repulsive interaction between the PEG chains and the MAA molecules. This phenomenon 
is commonly known as decomplexation.  
While there is hydrogen bonding between the PMAA and the PEG chain, the 
bonds can be disrupted. It has been shown that the methyl group of PMAA acts as an 
electron receiver and stabilizes the carboxylic acid group. The increase in electron 
receiving due to the methyl group causes an increase in the stability of the carboxylic 
acid’s hydrogen bonding, further stabilizing the complexation.[22]  
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Dynamic and equilibrium swelling studies were performed to investigate the pH 
sensitivity and water uptake of these samples with the incorporation of the aldehyde 
modified PEGMA in comparison to two control samples of PMAA and P(MAA-EG). 
The objective being to indicate that incorporation of the new aldehyde modified PEG 
tethers has no negative effect on the swelling or pH sensitivity of the hydrogels. The 
dynamic water uptake for each formulation is shown in Figures 4.3a and b. All 
formulations maintain pH sensitivity with a transition around a pH of 5.8. All 
formulations have similar swelling ratios with high points of 1.5 and low points of 1.0 
with one exception. The PMAA formulation has a maximum of 3.3 and a minimum of 
1.4 due to the lack of increased hydrogen bonding brought by the PEG tethers.  
The equilibrium water uptake for each formulation is shown in Figure 4.4. All 
formulations maintain pH sensitivity with a transition around a pH of 5.7. All 
formulations have similar swelling ratios with a maximum of 6.8 and minimum of 1.4, 
with one exception. The PMAA formulation has a maximum of 13.9 and a minimum of 
2.8 due to the lack of increased hydrogen bonding brought by the PEG tethers. The 
aldehyde modified PEGMA formulations for both dynamic and equilibrium swelling 
show continued pH sensitivity, as seen with the control formulations. 
All compositions in both the dynamic and equilibrium study showed pH 
sensitivity at pH of 5.8 and 5.7, respectively. There was also an increase in water uptake 
as pH increased, indicating that the addition of the aldehyde moiety does not affect the 
bonds that cause complexation and decomplexation. Of note is the drop between the 
weight swelling ratio of the PMAA formulation. This was to be expected with fewer 
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ether group sites due to the lack of PEG chains, thus decreasing the hydrogen bonding 
and the carrier’s ability to keep fluid out. 
This study allows us to confirm that the new tethers do not affect the desired 
properties of the pH sensitive hydrogels. Thus, we expect that the new carriers could 
maintain the same characteristics through the oral delivery process. 
Insulin Loading and Release Analysis 
 
 Insulin load and release studies were performed to determine how incorporation 
of the aldehyde modified PEGMA tethers would affect release characteristics. To 
determine any detrimental effect by the new aldehyde tethers, load and release studies 
were performed on the highest aldehyde modified PEGMA tethered formulation (3.3%). 
This has implications because of the success of prior work with pH sensitive 
hydrogels.[23] As discussed previously, RP-HPLC was used to determine that the 
amount of insulin loaded was at 93%. The fractional insulin released is shown in Figure 
4.5. The graph shows a minimum of 0.19 after 10 minutes at the first time point and then 
an exponential increase to 0.73 at the last time point of three hours. 
This study allows us to confirm that insulin release is still possible with the new 
tethers of the pH sensitive hydrogel. It is expected that these systems could maintain 
significant insulin release with potentially more adhesion. 
Adhesion Analysis 
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Adhesion studies were performed to investigate the effectiveness of the chemical 
Schiff’s linkage in aiding mucoadhesion when compared to the interpenetration and 
hydrodynamic forces seen in the control formulations in both dry and wet conditions.  
During the mucoadhesive experiments, the hydrogel disks were previously 
swollen in a buffer solution of pH 7.4 for 10 minutes. The first step necessary for the 
formation of a mucoadhesive bond between a polymer and the mucus is the wetting and 
swelling of the polymer. This step is crucial since the amount of water imbibed by the 
polymer at the time of adhesion will affect the interaction of the system with the mucus at 
the interface. Ten minutes of exposure to a buffer solution was sufficient to swell the 
system to conditions similar to those in the upper small intestine. This value simulates the 
physiological situation of a hydrogel traveling through the GI tract to the upper small 
intestine, where it is unswollen under the conditions described above, to the target site of 
adhesion, where it starts swelling and decomplexing.  
Different PEG-tethered designs were studied. The objective was to improve the 
mucoadhesive performance of a crosslinked poly(methacrylic acid) hydrogel, a well-
known mucoadhesive polymer, by decorating it with PEG tethers that have different 
adhesive moieties. The PEG tethers in this research were decorated with an aldehyde 
functional group. The basic P(MAA-EG) hydrogel utilizes many secondary chemical 
interactions. These secondary chemical interactions include ionic bonds, van der Waals 
interactions, and hydrogen bonding, with hydrogen bonding probably being the most 
important secondary interaction in mucoadhesion. Some functional groups that form 
hydrogen bonds are hydroxyls and carboxyls, which are both present on the basic 
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P(MAA-g-EG) system. However, while these types of forces are weak, numerous 
interaction sites led to strong mucoadhesion.[24] Upon entering the high pH conditions of 
the upper small intestine, hydrogen bonds are formed between the hydrogel and the 
mucus. There are some ionic interactions but not a significant amount. These secondary 
forces hold long enough for swelling and, as a result, interdiffusion will take place. This 
happens because the PEG chains are not interacting with the poly(methacrylic acid) 
backbone at the higher pH conditions. Consequently, the PEG chains are able to diffuse 
through the mucus and enhance mucoadhesion. The aldehyde moiety will complement 
these interactions with the addition of another possibly stronger chemical reaction with 
that of a Schiff’s base covalent linkage. This occurs when the aldehyde forms a chemical 
linkage with an amine functional group similar to those found on the N-terminus of the 
glycoproteins that help compose the mucus layer that coats the small intestine. 
Figures 4.6a and b show typical graphs of the force of detachment (N) vs. 
displacement (m) curves. The two graphs are of the lowest and highest order results 
retrieved from testing, respectively. This can be seen in the overall increase in the 
magnitude of the maximum force on the y-axis with Figure 4.6a peaking at 0.09 N and 
Figure 4.6b peaking at 0.35 N. Figure 4.6a shows the curves obtained in the tensile 
experiment present three different regions indicated with the letters A, B, and C. From 
point A to B, the disk is completely in contact with the mucin solution and the graph 
peaks at a maximum force as the two surfaces begin to detach. A large force is necessary 
for starting the detachment process. In the second portion of the curve, from point B to C, 
the graph begins decaying as the mucin solution detaches and moves to the exterior 
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portion of the disk. The graph begins to tail off, corresponding to the only contact with 
the disk, being through a taut string of mucin. Point C indicates the break point, where 
the two surfaces completely detach causing the graph to return to zero, ending the 
experiment. The work of adhesion (µJ) was calculated to be the area under the curve. 
Figure 4.7 shows the work of adhesion (µJ) for PMAA, P(MAA-EG) and all three 
weight percentage ratios of aldehyde modified PEGMA (0.06%, 0.6% and 3.3%) in 
ambient surroundings with 2 wt% mucin solution and PBS buffered bath with 20 wt% 
mucin solution. Figure 4.7 shows a minimum of 10.7 µJ for the PMAA formulation in 
ambient surroundings and a maximum of 48.1 µJ for the 3.3% aldehyde modified 
PEGMA formulation in PBS buffered bath surroundings. 
The data shows a trend of increasing adhesion from no tethers in the case of 
PMAA to those with tethers, as well as an increase in adhesion with an increase in the 
amount of aldehyde-modified PEGMA. This is the case for both ambient and buffered 
bath conditions, although the trend is not seen with the buffered bath conditions until 
reaching the higher percentages of aldehyde modified PEGMA. This indicated that 
interpenetration forces cause an initial increase in adhesion from PMAA to P(MAA-EG) 
but that the addition of the added chemical bonding through the Schiff’s linkage causes a 
greater increase in the adhesion and adhesion will only increase with more aldehyde 
modified PEGMA due to the availability of more bonding sites. 
Also of note is the overall increase in the force of adhesion between the ambient 
and PBS buffered bath solutions, especially for the PMAA formulation. This occurs due 
to the added swelling that takes place within the water bath. As stated previously, the 
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PMAA formulation has a larger water uptake than that of any other formulation. This is 
due to the lack of the hydrogen bonding that takes place between PEG and PMAA in all 
tethered formulations. These hydrogen bonds cause for tighter junctions and smaller 
uptake of fluid, thus swelling. Since PMAA does not have these interactions, it has more 
uptake of fluid and more swelling, which is still taking place in the water bath during the 
mucoadhesion experiments. The increased swelling allows for more of a wicking action 
to take place between the hydrogel and the mucin substrate, causing an increase in 
adhesion. 
This study allowed us to determine the increased adhesion the aldehyde modified 
PEG tethers provide for. With increased adhesion over other formulations, these new 
materials could potentially improve drug delivery due to increased residence time in the 
upper GI tract.  
Conclusions 
 
 The present work was performed to determine the effectiveness of using chemical 
linkages by utilizing a reactive functional group, in this case an aldehyde moiety, to 
increase the limited adhesion of the hydrogel. The better adherence to the small intestine 
would lead to increased residence time, release at the delivery site, and would 
presumably affect the bioavailability of the protein. Hydrogels with and without PEG 
tethers and with varying percentages of aldehyde modified PEG tethers were synthesized 
and characterized to determine any improved adhesive capacity without affecting the 
overall characteristics of the oral delivery device. Swelling studies showed that the 
aldehyde functionalized hydrogels retained their pH sensitivity at pH=5.5. Release 
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studies showed the aldehyde functionalized hydrogels maintained the fractional insulin 
release seen in previous work with nonfunctionalized hydrogels. Widely accepted in vitro 
tensile testing showed improved adhesive capacity with increased chemical linkages with 
the aldehyde moiety in both dry and wet conditions. These findings indicate the potential 
these functionalized hydrogels have for improved oral drug delivery.  
  
 69 
References: 
 
1. Davis, S., Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the 
Endocrine Pancreas. 11 ed. Goodman and Gillman’s The Pharmacological Basis of 
Therapeutics, ed. L. Brunton, J. Lazo, and K. Parker. 2006, Columbus: McGraw-Hill Co. 
2. Peppas, N.A. and P.A. Buri, Surface Interfacial and Molecular Aspects of 
Polymer Bioadhesion on Soft Tissues. J Controlled Release, 1985. 2: p. 257-275. 
3. Nagai, T., Adhesive topical drug delivery system. J Controlled Release, 1985. 2: p. 
121-134. 
4. Nagai, T. and Y. Machida, Mucosal adhesive dosage forms. Pharm Int, 1985. 6: p. 
196-200. 
5. Bremecker Kd, Strempel H, and G. Klein, Novel concept for a mucosal adhesive 
ointment. J Pharm Sci, 1984. 73: p. 548-552. 
6. Luessen, H.L., et al., Mucoadhesive polymers in peroral peptide drug delivery .4. 
Polycarbophil and chitosan are potent enhancers of peptide transport across 
intestinal mucosae in vitro. Journal of Controlled Release, 1997. 45(1): p. 15-23. 
7. Langer R and N. Peppas, Advances in Biomaterials, Drug Delivery, and 
Bionanotechnology. Aiche Journal, 2003. 49: p. 2990-3006. 
8. Peppas, N., Controlling protein diffusion in hydrogels, in Trends and Future 
Perspectives in Peptide and Protein Drug Delivery, VHL. Lee, M. Hashida, and 
Y. Mizushima, Editors. 1995: Horwood, Chichester. p. 23-27. 
9. Peppas, N.A., et al., Physicochemical, foundations and structural design of 
hydrogels in medicine and biology. Annual Review of Biomedical Engineering, 
2000. 2: p. 9-29. 
10. Ratner, B. Synthetic hydrogels for biomedical applications. in ACS Symp. Ser. 
1976. 
11. Hoare, T.R. and D.S. Kohane, Hydrogels in drug delivery: Progress and 
challenges. Polymer, 2008. 49(8): p. 1993-2007. 
12. Lowman, A.M. and N.A. Peppas, Analysis of the complexation/decomplexation 
phenomena in graft copolymer networks. Macromolecules, 1997. 30(17): p. 4959-
4965. 
13. Lowman, A.M. and N.A. Peppas, Molecular analysis of interpolymer 
complexation in graft copolymer networks. Polymer, 2000. 41: p. 73-80. 
 70 
14. Ching Hs, et al., Bioadhesive polymers as platforms for oral controlled drug 
delivery: II Synthesis and evaluation of some swelling, water-insoluble 
bioadhesive polymers. J Pharm Sci, 1985. 74: p. 399-405. 
15. Park, H. and J.R. Robinson, Physico-chemical properties of water insoluble 
polymers important to mucin-epithelial adhesion. J Controlled Release, 1985. 2: 
p. 47-57. 
16. Park, J. and J.R. Robinson, Mechanisms of mucoadhesion of poly(acrylic acid) 
hydrogels. Pharm Res, 1987. 4: p. 457-464. 
17. Peppas, N.A., Devices based on intelligent biopolymers for oral protein delivery. 
International Journal of Pharmaceutics, 2004. 277(1-2): p. 11-17. 
18. Huang, J., Syntheses of Polyethylene Glycol (PEG) with Different Functional 
Groups at Each End: I - Preparation of Monotrityl PEG Using Polyvinyl Alcohol 
(PVA) Matrix. J. Applied Polymer Sci., 1992. 46: p. 1663-1671. 
19. Huang, J. and Y. Hu, The Syntheses of Polyethylene Glycol (PEG) with Different 
Functional Groups at Each End: II - Synthesis of a series of Monosubstituted 
PEG via Polyvinyl Alcohol (PVA) as Support, J. Applied Polymer Sci., 1993. 47: 
p. 1503-1511. 
20. Brinkley, M., A Brief Survey of Methods of Preparing Protein Conjugates with 
Dyes, Haptens, and Cross-Linking Reagents. Bioconjugate Chem., 1992. 3: p. 2-
13. 
21. Griffith Wp, et al., Preparation and use of tetra-n-buylammonium per-ruthenate 
(TBAP reagent) and tetra-n-propylammonium per-ruthenate (TPAP reagent) as 
new catalytic oxidants for alcohols. J. Chem. Soc. Chem. Commun., 1987: p. 
1625-1627. 
22. Lowman, A. and N. Peppas, Molecular analysis of interpolymer complexation in 
graft copolymer networks. Polymer, 2000. 41: p. 73-80. 
23. Tuesca, A., et al., Complexation hydrogels for oral insulin delivery: effects of 
polymer dosing on in vivo efficacy. J Pharm Sci, 2008. 97(7): p. 2607-18. 
24. Mathiowitz E, C.D., Jacob J, and Santos C, Bioadhesive Drug Delivery Systems, 
in Encyclopedia of Controlled Drug Delivery M. E, Editor. 1999, Wiley: New 
York, NY. p. 9-45. 
 
 
 71 
 
 
Figure 4.1. Structure of aldehyde modified PEGMA 
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(a) 
 
(b) 
Figure 4.2a and b. FTIR spectra (top to bottom): P(MAA-EG) hydrogel with 3.3% 
aldehyde modified PEGMA in dry state, Schiff’s reagent for aldehydes and P(MAA-
EG) hydrogel with 3.3% aldehyde modified PEGMA after being in Schiff’s reagent 
and washed in DI water.  
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(a) 
 
(b) 
Figure 4.3a and b. Dynamic swelling results to gauge pH sensitivity. (a) Dynamic 
swelling of all formulations (b) close up of four formulations 
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Figure 4.4. Equilibrium swelling of polymer discs of all formulations after spending 
48 hours in each of five buffers to gauge pH sensitivity 
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Figure 4.5. Fractional insulin release of 3.3% aldehyde modified PEGMA hydrogel 
formulation 
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Figure 4.7. Work of adhesion (µJ) from instron testing with ambient and buffered 
bath data for all formulations 
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Chapter 5: Atomic Force Microscopy as a Tool for Determining 
Adhesion of Poly Methacrylic Acid pH sensitive Hydrogels In Vitro 
Introduction 
 
There have been many advancements in oral drug delivery but it has also met less 
success than other delivery methods due to the limits associated with the physiology of 
the gastrointestinal (GI) tract. This limits the effectiveness of the delivery system due to 
difficulties with transport across the lumen of the intestine and low bioavailability. One 
way to combat this is through improved adhesion at the site of delivery. To do this, it is 
important to understand these interactions between the polymer interface and mucus 
surface to improve adhesion and thus the efficacy of oral delivery.  
Mucoadhesion is known to be a very complex phenomenon when dealing with the 
different properties of the polymer, tissue and environment. There have been numerous 
theories developed to describe the phenomenon of mucoadhesion. There is no single 
theory that is widely accepted, but rather a combination of theories typically used in 
describing the phenomena. The theories range from the adsorption theory to the diffusion 
theory, both of which are two of the main theories we have focused on thus far in this 
research. Briefly, the adsorption theory deals with adhesion through secondary forces and 
the diffusion theory describes the interpenetration of polymer chains into the interfacial 
region. There are also other avenues of adhesion, such as creating stronger covalent 
bonds like that of the Schiff’s base reaction, which utilizes an aldehyde bonded to an 
amine group. Overall, the nature of the interaction between the system and mucus layer is 
not yet fully understood [1-4].  
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There have been several in vitro methods put forth over the last several decades to 
try to gauge this interaction in various ways. There has been little headway with all 
methods having some limitation [5, 6]. Looking at the methods used in this research, the 
tensile testing is a staple amongst adhesive testing which gauges the tensile force needed 
to separate a cylindrical disk from animal mucus and used to calculate the overall work of 
adhesion [7]. The falling film technique places microparticles along a portion of small 
intestine before having a solution poured over it. The eluted particles are determined and 
are an indication of the mucoadhesive properties [8]. Tensile tests and the trough method 
are used to give a good indicator of the bulk adhesion but have a forced initial interaction 
not seen in the small intestine [9]. 
The flow channel method uses polymer particles placed on a mucus surface. 
Laminar air flow is passed over the particle with photographs taken to analyze the 
behavior [10]. This method does not give quantitative results and as with the tensile 
testing and trough method have a forced interaction between particle and mucus layer. 
Both the BIACORE™ and mucin particle methods give indications of the affinity 
that a polymer particle has with mucin in the initial stages of attraction but both fail to 
give any data of the strength of the bond formed and thus the ability of the particle to 
maintain adhesion despite various forces that act upon it in the GI tract. 
Since adhesion is so complex, there is a need for a better understanding of how 
substances interact through every stage of adhesion on a molecular level. Improved 
knowledge of molecular level interplay will enable further understanding of bulk level 
adhesion. One way of doing this, is by developing an improved model for in vitro testing. 
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 Atomic force microscopy (AFM) is primarily used for imaging purposes, but it 
can also be a powerful tool used to investigate and probe the mechanical and viscoelastic 
properties of thin films on the nanoscale [11]. Scientists have used AFM as a new avenue 
for providing images at a resolution higher than that obtained by light microscopy. The 
use of AFM has grown increasingly in the biological sciences and has now been 
established as a versatile tool to address the structure, properties and functions of 
biological specimens [12, 13]. AFM is unique for its ability to provide three-dimensional 
images of biological structures in ambient conditions as well as under physiological 
conditions with impeccable resolution. This is done by moving a sharp probe mounted on 
the end of a flexible cantilever across the surface of the substrate. In the conventional 
contact mode AFM, the probe is in continuous contact with the surface as the substrate is 
scanned. Tapping mode AFM, causes the cantilever to be oscillated at a high frequency, 
resulting in only intermittent contact between the probe and cell surface. The oscillations 
of the cantilever are reduced and energy lost once the probe contacts the surface. This 
reduction in oscillation is used to identify and measure features along the surface of the 
substrate [14, 15]. 
In addition, it can also measure forces with remarkable sensitivity and positional 
precision. This mode is called force spectroscopy. In this mode, the cantilever deflection 
is recorded as the tip is pushed towards the sample and retracted from it. Quantitative 
physical properties can be obtained from this data, such as local elasticity, surface forces, 
surface charge and hydrophobicity, and to measure inter- and intramolecular interactions. 
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This can ultimately provide new insights into the molecular basis of processes such as 
protein folding and receptor–ligand interactions [14, 15]. 
For the purposes of this research, this method would allow for new insight into 
the molecular interactions between the hydrogel and the substrate at each point of 
adhesion on the molecular level by allowing the hydrogel to initiate the interaction and 
begin bonding before being pulled off to record its adhesive nature. These measurements 
can gauge the effect of the physical and chemical bonds of the polymethacrylic acid, the 
grafted PEG tethers, and various other attached moieties on the molecular level which 
can then be compared on a bulk scale as needed. Other works have used AFM in this 
fashion while modifying AFM probes to measure the adhesion characterisitic of 
substrates such as living cells. However, these modified tips are chemically made with 
small covalently bonded molecules as opposed to larger crosslinked particles [16, 17]. 
The goal of this research is to develop a new in vitro testing method for 
understanding the adhesive molecular interactions between copolymers, such as those 
used in drug delivery vehicles, and the substrates they are to adhere to throughout the 
body such as the mucus layer. To begin, we will be exploring the interactions between 
previously made pH sensitive hydrogel microparticles and mucus solution. This would be 
the first instance of either material being use in AFM force modulation. 
Materials and Methods 
Hydrogel Synthesis 
 
The methacrylic acid (MAA) monomer was passed through a dehibit column to 
remove the inhibitor. The polymer films were prepared by free radical UV 
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polymerization. The diluted monomer mixture was composed of methacrylic acid (MAA, 
Sigma, St. Louis, MO) and both PEGMA and aldehyde modified PEGMA [18] with a 
molecular weight of approximately 500. Irgacure® 184 (1-hydroxy-cyclohexyl-
phenylketone, Ciba-Geigy, Hawthorne, NY), which was used as a photoinitiator, and 
tetraethylene glycol dimethacrylate (TEGDMA, Polysciences Inc. Warrington, PA), 
which was used as a crosslinking agent, was also incorporated. Deionized water and 
ethanol were used as solvents. The monomer solution was made in a ratio of 1:1, 
MAA:EG units, containing 3.3% aldehyde modified PEGMA incorporated with 
unmodified PEGMA as well as solutions of P(MAA-EG) with no aldehyde modified 
PEGMA. TEGDMA was added as 1 mol% of the total monomer and Irgacure® 184 
added as 1 wt% of the total monomer.  
The monomer solution was dissolved with a 50:50 monomer to solvent ratio by 
weight. The total solvent weight was composed of equal parts deionized water and 
ethanol. Once all components were added to the monomer mixture, the solution was 
sonicated until all materials were dissolved into solution. The mixture was purged with 
nitrogen for 20 minutes to remove oxygen, which acts as a free radical scavenger. The 
solution was pipetted between two glass slides (75 mm X 50 mm X 1 mm) separated by a 
0.8 mm Teflon® spacer. The slides were placed under a UV light (Efos Corporation, 
Ultracure 100ss, High pressure mercury lamp, Mississauga, Ontario, Canada) and 
allowed to polymerize for 30 minutes.  
After polymerization was complete, the thin films were washed with deionized 
water daily for one to two weeks to remove all unreacted components. After washing, the 
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films were dried under a vacuum (Heraeus VTR-5036, Heraeus Instruments GmbH., 
Hanau, Germany) for two days at approximately 30° C. Hydrogel films were crushed, 
and sieved with a mesh size of 45µm. Images of particles were taken on a light 
microscope and processed using an image processing program. Particle size distribution 
was found to be 8.5 mm with a standard deviation of 5.8mm. 
AFM Tip Mounting 
 
 The microparticles were mounted on the ends of tipless AFM probes (Veeco 
Probes, Camarillo, CA). The probes have two tips on each side, each corresponding to 
different k values. The tip with the k value comparable to what was calculated beforehand 
was used. First, the AFM probe was mounted onto a pipette tip, placed onto a 
micromanipulator, and adjusted until the desired tip was in view under the light inverted 
microscope. Next, the microparticles were mixed with a cyanoacrylate adhesive, placed 
onto the end of another pipette tip and attached to the opposing micromanipulator. The 
manipulators were used to set to fine mode to insure slow movement between tips and 
decrease the likelihood of breaking the probe. The microparticles were lowered over the 
tip in the negative z direction repeatedly until a microparticle was adhered to the tip. 
Pictures were taken with a camera attachment to the microscope at a magnification of 
20 X for each tip and scale bars added to determine the diameter of each particle. 
AFM Experiments 
 
 The previously made tip was placed into the AFM mount, secured, and brought 
into view under the microscope fixture. The laser used to read the deflection of the 
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cantilever was aligned with the tip according to the signal markers of the computer 
software. All sampling parameters were set to the default settings. The sample substrate 
was prepared and placed beneath the tip. A 20wt% mucin solution was made and a small 
amount added to a microslide (3 in X 1 in X 1 in) before being spin-coated at 2500 RPMs 
for 30 seconds. Once the sample was in place, the tip was lowered to within a few 
micrometers and engaged, allowing force curves to be sampled at different deflection 
settings. The data was recorded, resulting in the plotting of deflection (nN) vs. z position 
(nm). After normalizing the curve (subtracting the trace from the retrace curve) the 
trapezoidal rule was used to calculate the work of adhesion (nJ). This is discussed in 
further detail at the end of this section. 
 These tests were also carried out in wet mode, which simulates the conditions of 
the GI tract. The microparticle tips were hydrated previous to testing by the addition of 
PBS buffer (pH 7.4) for 10 minutes. All other procedures are the same. Tipless probes 
were also tested on clear glass slides and on mucin coated glass slides as controls. 
K Value Calculations 
 
In order to optimize the ratio between the stiffness (k-value) of the cantilever and 
the expected mechanical properties, an estimate was made on the predicted contact force 
between the sample and probe. These estimates were made from previously conducted 
Instron tensile tests with specimens of diameter = 14 mm and thickness = 0.8 mm. The 
Veeco probes (Number NP-010, Camarillo, CA) have k-values ranging from 0.06-0.58 
N/m. From these tests the area of a 14 mm diameter disk used, A1 = 1.54 × 10
-4
 mm
2
 and 
the maximum force achieved, Fmax = 0.01 N, was obtained. 
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These numbers were used to quantify the stress, σ,  
 1
max
A
F
=σ  , (2) 
sustainable by the sample under tensile load. By estimating the contact area, A2 of a 2000 
µm
2
 microparticle on a 100 mm long probe, deflecting by approximately 1 µm (x), we 
obtained a k-value of approximately 0.12 N/m with equations 3 and 4 indicating which 
tipless probe should be used. The probe used had a k-value of 0.12 N/m and had a 
nominal length of 205 µm, and width of 40 µm. 
 
 
 2
AFnew σ=  (3)
 
 x
F
k new=   (4) 
 
AFM Analysis 
 
The raw data from the AFM experiments was analyzed to give the work of 
adhesion. The data was recorded, resulting in the plotting of deflection (nN) vs. z position 
(nm) and presented in two sets, trace and retrace. The curve was normalized by 
subtracting the retrace from the trace data. With this done the adhesion curve is now in 
the positive regime. The trapezoid rule was used to determine the area under the curve 
and give the work of adhesion (nJ). This work of adhesion was then multiplied by the k 
value of the tip that was used on the AFM probe and then divided by the surface area of 
the particle that was used to normalize the data since different probes will have different-
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sized particles attached. In the event that the adhesion curve was cut off it was pieced 
together by extrapolating the curve to a point and then carried out in the same way as just 
stated. 
 
Results 
 
AFM Tips  
 
Pictures were taken of each microparticle mounted probe to confirm adherence to 
the tip and determine the diameter and topography of each microparticle that would be 
used in testing. This is important to know the appropriate estimated surface area in 
contact with the mucin substrate which will be used to normalize the data at the end of 
the calculations. 
Three probes were used successfully comprised of two control samples of PMAA 
and P(MAA-EG) as well as the 3.3% aldehyde modified P(MAA-EG) sample were used 
with no preswelling, figures 6.1-6.3. Two more samples comprising P(MAA-EG) and 
3.3% aldehyde modified P(MAA-EG) were used with the 10 minute preswelling before 
being used in the AFM, Figures 6.4 and 6.5. A PMAA sample was not used in 
preswelling testing due to its higher swelling ratio. The higher swelling ratio causes the 
hydrogel to increase to a size that makes interactions difficult with the substrate. In each 
picture, scale bars were used which gave diameters of 34, 41, 24, 34, and 45 µm 
respectively. The topography of each particle is spherical in nature even though it has 
some rough and jagged areas, leading us to use the surface area of a sphere to determine 
the surface area of the particles to be used in normalization of the final data analysis. 
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This allows us to confirm that the particles adhered to the tipless probes. 
Secondly, it gives us the dimensions of each particle and a closer look at the topography 
allowing us to determine the best way to calculate the surface area that would be in 
contact with the mucin in experimentation. 
AFM Experiments 
 
AFM experiments were run using the previously made tips. Raw data was 
gathered in the form of trace and retrace data plotted as deflection (nN) vs. z position 
(nm). These graphs are used for two reasons. The first is to determine that adhesion is 
occurring. The second is to use the graphical data to calculate the quantitative results of 
adhesion. 
Determination of adhesion in AFM force modulation is proven by observing the 
trace and retrace data, Figure 6.6. Trace data is from point 1 to point 3 seen and the 
retrace data is from point 3 to point 6. Briefly, moving from point 1 to 2 the probe tip is 
brought closer to the surface until the natural attraction between the surface and the probe 
causes each to come into contact and bind. Upon contact, the cantilever deflection will 
increase from point 2 to 3 as the fixed end of the cantilever is brought closer to the 
sample, causing an increase in deflection in the positive regime completing the trace data. 
After loading the cantilever to a desired force value, it begins to withdraw, moving from 
point 3 to 4. We are able to determine if adhesion is present at this point as the retrace 
data moves past the initial contact point from the trace data indicating adhesion during 
contact with the surface. With two perfectly rigid, frictionless surfaces, the retrace line 
would follow the trace exactly. Point 4 to 5 occurs as the cantilever is pulled away and 
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adhesion is broken from the surface substrate. Points 5 to 6 are the cantilever moving 
completely away from the surface.  
Samples from AFM force modulation testing performed with PMAA and 3.3% 
aldehyde modified P(MAA-EG) microparticle tips are shown in Figures 6.7 and 6.8 
respectively. Each shows a distinct curve under the initial interaction point of the trace 
data indicating adhesion between the surface mucin and the microparticle tips did occur. 
After confirmation, each sample probe was tested in triplicate and used to determine 
quantitative results. This was done by subtracting the retrace from the trace data to give 
the adhesive curve in the positive regime. The area underneath this curve was found and 
determined to be the work of adhesion. This allows us to confirm that adhesion did occur 
with the particle loaded tips and gather the data for each particle to quantitatively gauge 
the work of adhesion.  
AFM Analysis 
 
AFM force modulation studies were performed to investigate first the 
effectiveness of using AFM in determining adhesive properties of hydrogels on a 
molecular level. This data can then be used in two ways. First, it can be used to determine 
the importance of such adhesive properties of secondary forces, interpenetrative forces 
and various other covalent linkages on a molecular level. Second, it can be scaled up and 
compared with previous bulk adhesion experiments.   
During the AFM experiments, the hydrogel tagged tips comprised of PMAA, 
P(MAA-EG) and 3.3% aldehyde modified P(MAA-EG) were used dry and unswollen for 
one series of experiments and for a second set P(MAA-EG) and 3.3% aldehyde modified 
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P(MAA-EG) were preswollen with a buffer solution of pH 7.4 for 10 minutes. The first 
set of unswollen tips were used to give a proof of concept, but also to see what adhesive 
interactions occur without the hydrodynamic forces that are involved after swelling. The 
second set was preswollen because as stated in previous chapters, the swelling is a key 
first step in the formation of a mucoadhesive bond between a polymer and the mucus due 
to the wetting and swelling of the polymer. Ten minutes of exposure to a buffer solution 
was sufficient to swell the system to conditions similar to those in the upper small 
intestine.  
The hydrogels used in this research have several different avenues for creating 
adhesive bonds. The basic P(MAA) and P(MAA-EG) hydrogels utilizes many secondary 
chemical interactions including ionic bonds, van der Waals interactions, and hydrogen 
bonding, with hydrogen bonding probably being the most important secondary 
interaction in mucoadhesion. However, while these types of forces are weak, numerous 
interaction sites lead to strong mucoadhesion.[19] Upon entering the high pH conditions 
of the upper small intestine, these secondary forces hold long enough for swelling and, as 
a result, interdiffusion will take place. This happens because the PEG chains are not 
interacting with the poly(methacrylic acid) backbone at the higher pH conditions. 
Consequently, the PEG chains are able to diffuse through the mucus and enhance 
mucoadhesion. The aldehyde moiety complements these interactions and, as shown 
previously, adds another stronger chemical reaction with that of a Schiff’s base covalent 
linkage. This occurs when the aldehyde forms a chemical linkage with an amine 
functional group similar to those found on the N-terminus of the glycoproteins that help 
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compose the mucus layer that coats the small intestine. Using the AFM we can try to 
understand which of these forces is more significant for the overall adhesion of the 
hydrogel. 
To separate theses forces from the data we have collected we must look at the first 
law of thermodynamics. This law states that energy is conserved. If we were to look at 
these experiments in a perfect scenario we would have a perfectly rigid cantilever or a 
perfectly elastic substrate that was also frictionless and a cantilever that was perfectly 
elastic. In either scenario, as the tip is brought into contact with the surface, the AFM 
laser move along a perfectly retraceable path. Of course, this is not seen because the 
interactions between the tip and substrate are not perfectly elastic and there is no non-
zero coefficient of friction. These discrepancies can be attributed to the energy being 
dissipated as acoustic or thermal energy which increases more due to the addition of the 
deformable hydrogel to the tip. Bringing us back to the first law of thermodynamics, we 
should find that the summation of all chemical and mechanical energies is equal to the 
work done by the system or zero in this ideal scenario meaning that all mechanical 
energy that is dissipated is absorbed chemically via,  
 0=+ EmEc , (5)
 
 where Ec is chemical energy and Em is mechanical energy. 
We can further break this equation down into the three basic components of the 
system: the hydrogel, the mucin substrate, and the silicon of the cantilever tip. Where 
Ec,muc, Ec,HG, and Ec,si are the chemical energies of the mucin, hydrogel and silicon 
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respectively and Em,muc, Em,HG, and Em,si are those same quantities for mechanical 
energies. Equation 5 then becomes, 
 
( ) ( ) 0,,,,,, =+++++ simHGmmucmsicHGcmucc EEEEEE , (6) 
In a nonideal scenario, such as the experiments in this research, equation (6) will 
be equal to the amount of energy absorbed by the sample and can be found by integrating 
the area of the curve of data given from the trace and retrace curves. To find the forces 
associated with the chemical bonding, we must determine the mechanical energies and 
subtract them from that force. Em,si is the mechanical energy of the deformation of the 
silicon cantilever. This can be determined by running a force curve on a tip with no 
hydrogel microparticle and bringing it into contact with a smooth glass surface. This 
value was found to be 2.95 nJ. 
The other two mechanical energies, Em,muc, and Em,HG, can be determined by 
experiments with a tip with no hydrogel but with mucin as the substrate instead of just a 
glass surface. From this we can decouple these energies. This value was found to be 
24.53 nJ. Ec,si  is zero since there are no chemical interactions with the silicon of the 
cantilever.    
Table 6.1 shows the values for all formulations in the dry AFM testing and 
preswelling AFM testing along with their standard deviations. The previously found 
mechanical energies can now be subtracted from these values giving the forces associated 
with chemical bonding. These values can then be normalized by dividing by the surface 
area of each individual microparticle giving the normalized forces associated with 
chemical bonding. These new values can be seen in Table 6.2. There are several things to 
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note in these values. First, the work of adhesion of all formulations in dry testing 
produced negative values as opposed to the preswollen values which were all positive 
values. This could be due to the sample having more of a repulsive force acting upon it 
from the mucin substrate than an attractive force as seen with the preswollen values. The 
repulsive force could be due to the lack of sufficient bonding due to secondary forces 
with a lack of hydrated surroundings or swelling of the hydrogel itself. Also, a lack of 
swelling of the hydrogels could cause both the PEG tethers and aldehyde modified PEG 
tethers to remain on the interior of the hydrogels and prevent them from interacting with 
the mucin substrate also preventing any interpenetration or Schiff’s base covalent 
bonding to occur. The lack of chemical bonding energies results in the mechanical 
energies doing more work in the system and thus the negative chemical bonding energies. 
The second thing of note is that in both the dry and preswollen values, the 3.3% aldehyde 
modified formulations all had a larger work of chemical bonding adhesion than either of 
the controls formulations. This maintains the trend we saw in earlier work with bulk 
testing on the Instron tensile testing machine.  
To further compare these results to the bulk testing in vitro model used previously 
in this research, the normalized data is scaled up to a bulk level. This is done by 
multiplying the normalized values of the AFM data by the area of a uniform cylindrical 
disk used in Instron testing and converting to microjoules. The area of a cylindrical disk 
for PMAA was 9.5 X 10
13 
nJ while the other two formulations were 1.54 X 10
14
 nJ. A bar 
graph comparing all three formulations used in Instron testing, and the scaled up values 
for the dry and preswollen AFM testing, figure 6.9. The values for the Instron testing are 
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10.73 µJ, 21.17 µJ and 37.4 µJ for PMAA, P(MAA-EG) and 3.3% aldehyde modified 
P(MAA-EG) hydrogels respectively. The values for the dry AFM testing are -591.6 µJ, -
792.49 µJ and -1361.43 µJ for PMAA, P(MAA-EG) and 3.3% aldehyde modified 
P(MAA-EG) hydrogels respectively. The values for the preswollen AFM testing are 
1563.81 µJ and 2801.14 µJ for P(MAA-EG) and 3.3% aldehyde modified P(MAA-EG) 
hydrogels respectively. 
Looking at the scaled up data, we can first see that the trend of increasing 
adhesion from the control formulations to the 3.3% aldehyde formulation holds true for 
all three testing methods. We see an overall increase of adhesion by 76%, 72% and 79% 
from the most adhesive control formulation to the 3.3% aldehyde formulation over 
Instron, dry AFM and preswollen AFM testing respectively. We also see that AFM 
values were two orders of magnitude greater than those found from the Instron tensile 
testing method. This is anticipated due to the increase in relative surface area of the 
microparticle in contact with the mucin substrate unlike that of the cylindrical disk used 
in Instron testing. This shows that we get as good, if not more, accurate adhesive results 
from this method since the actual administration of the drug delivery system would be 
through microparticles and not bulky cylindrical disks.  
Finally, we can use these results to determine the anticipated values each form of 
adhesion separately brings to the overall work of adhesion. Since the dry AFM data 
seems to have little chemical bonding energies due to lack of the hydrated environment 
and swelling we are unable to utilize this data for these purposes and must focus on the 
preswollen AFM data. Since we were unable to perform tests with P(MAA) due to its 
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higher swelling, ratio causing the hydrogel to increase to a size that makes interactions 
difficult with the substrate we must focus on the affects of just the Schiff’s base bonding 
from the aldehyde functional groups. Looking at the normalized data from Table 2, we 
see that there is an increase of adhesion of 8.03 X 10
-9
 nJ or an increase of the 79% we 
discussed previously from the tethered P(MAA-EG) to the 3.3% aldehyde modified 
formulation. The only difference between the two formulations is the addition of the 
aldehyde moiety signifying that this addition has a significant effect on the adhesive 
properties of the hydrogel outside the adhesive effects of secondary and interpenetrative 
forces.  
This study allowed us to confirm the validity of AFM force modulation as an 
effective model for in vitro adhesion testing of drug delivery vehicles specifically pH 
sensitive hydrogels on a molecular level. Using the data gathered from testing we were 
able to show that the values were as accurate, or more so, than that of the bulk testing 
Instron model. We also showed that while there is more work to be done to determine the 
exact importance of the secondary and interpenetrative forces we gauged the increased 
normalized force of adhesion and overall percent increase of adhesion with the addition 
of the aldehyde moiety.  
Conclusions 
 
The present work determined that AFM force modulation is an effective model 
for in vitro adhesion testing of drug delivery vehicles specifically pH sensitive hydrogels 
on a molecular level. Utilizing a more accurate in vitro method would bring new insight 
into the methods of adhesion and further the work of improving oral drug delivery 
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vehicles. Determining how to better adhere to the small intestine would lead to increased 
residence time, release at the delivery site, and would presumably affect the 
bioavailability of the protein. Hydrogels with and without PEG tethers and with aldehyde 
modified PEG tethers were synthesized and used in this study and compared with work 
previously done using the Instron tensile testing method. Microparticle-tagged AFM tips 
were made and confirmed for use in experimentation. All sample tips were engaged and 
successful force curves were recorded. The data gathered showed an overall increase of 
adhesion across all formulations when compared with the bulk testing. Preswollen AFM 
data was utilized to determine that the aldehyde moiety alone has an increase of 8.03 X 
10
-9
 nJ or a 79% increase on adhesion without the addition of secondary or 
interpenetrative forces. These findings indicate the potential this new method has for 
determining the effectiveness of both old and new forms of adhesion. 
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AFM dry testing Formulation Work of adhesion (nJ) 
  P(MAA)  4.86 + 0.15 
  P(MAA-EG)  0.30 + 0.07 
  3.3% aldehyde tethers 11.48 + 0.04 
AFM preswelling 
testing Formulation Work of adhesion (nJ) 
  P(MAA) N/A 
  P(MAA-EG) 140.04 + 3.14 
  3.3% aldehyde tethers 155.05 + 3.22 
 
Table 5.1. Work of adhesion (nJ) for all three hydrogel formulations used in both 
dry AFM testing and preswollen AFM testing. These are the straight values after 
integration of the trace/retrace curves with no other calculations involved. 
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AFM dry testing Formulation Work of adhesion (nJ) 
  P(MAA)  -6.23E-09 + 4.11E-11 
  P(MAA-EG)  -5.15E-09 + 1.30E-11 
  3.3% aldehyde tethers -8.84E-09 + 2.12E-11 
AFM preswelling 
testing Formulation Work of adhesion (nJ) 
  P(MAA) N/A 
  P(MAA-EG) 1.02E-08 + 2.83E-10 
  3.3% aldehyde tethers 1.82E-08 + 4.59E-10 
 
Table 5.2. Work of adhesion (nJ) for all three hydrogel formulations used in both 
dry AFM testing and preswollen AFM testing. These are the normalized values after 
integration of the trace/retrace curves, subtraction of the mechanical energies, 
divided by the surface area of each individual microarticle. 
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Figure 5.1. PMAA tagged tipless probe that was used during dry testing. 
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Figure 5.2. P(MAA-EG) tagged tipless probe that was used during dry testing. 
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Figure 5.3. 3.3% aldehyde modified P(MAA-EG) tagged tipless probe used during 
dry testing. 
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Figure 5.4. PMAA tagged tipless probe used during preswollen testing. 
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Figure 5.5. 3.3% aldehyde modified P(MAA-EG) tagged tipless probe used during 
preswollen testing. 
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Figure 5.6a and b. Trace and retrace curves from AFM force measurements and the 
accompanying probe positions. 
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Figure 5.7.Trace/retrace data from AFM of PMAA hydrogel in dry mode. 
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Figure 5.8. Trace/retrace data from AFM of 3.3% aldehyde hydrogel in dry mode.  
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Figure 5.9. Work of adhesion for P(MAA), P(MAA-EG) and 3.3% aldehyde 
formulations scaled up to bulk level values for the Instron, dry AFM and preswollen 
AFM testing. For AFM testing n = 3. For Instron testing n = 5. 
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Chapter 6: Synthesize and determine properties of pH sensitive 
hydrogels modified with the SlpA bacterial protein found in 
Lactobacillus Acidophilus 
Introduction 
 
In this chapter, we investigate an alternate method of adhering the hydrogel 
microparticles to the small intestine. This method utilizes a biological technique that 
allows adherence to cells and mucus unlike the more synthetic route previously discussed 
in chapter 4. The improved adhesion and selectivity should allow further headway into 
overcoming the obstacles that limit the overall drug bioavailability to ranges that are not 
commercially acceptable. [1-5] These obstacles range from enzymes that digest the 
proteins to difficulties with the transport of large molecules across the mucosa and 
epithelial cell layer. Novel carriers have been developed with desirable properties to meet 
these challenges with an eye towards improving adhesion at the site of delivery which 
would maintain the drug delivery system in a specific location in the body, have a 
prolonged duration of contact with the tissue, and increase the treatment efficiency since 
the drug is locally maintained at the site of transport. 
Bacteria have evolved over time into many types with various uses ranging from 
being destructive and causing infection, major illness, and even death, to those that are 
more beneficial by aiding digestion. The primary factors that dictate the tissue tropism of 
a microbe are its adhesive properties. When bacteria cannot adhere to target cells they are 
usually rapidly dispatched from the host. Adhesion may be the most important step in the 
colonization of mammalian tissues by both commensal and pathogenic bacteria. The 
adhesive process is initiated by cell-surface fibers called fimbriae or pili. These fibers 
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project bacterial lectins, also called adhesins, away from the bacterial surface, towards 
specific glycan receptors on the host cell. In most cases they are found to employ 
adhesins to exploit the diversity and virtually unlimited combinatorial potential of their 
carbohydrate receptors to ensure selective and finely tuned pathogen–host interactions 
[6]. 
Many are looking at ways of hindering this adhesive process of bacteria as a way 
to avoid the painful disease and infections that they can cause. [7-9] However, many have 
also used viruses and bacteria as a blueprint for how to improve drug delivery and other 
medical practices and treatments.[10, 11] The latter has allowed us to look at bacteria’s 
ability to adhere and utilize that for the purposes of drug delivery. Incorporating adhesive 
properties into a drug delivery system has many significant advantages that have already 
been stated. One specific advantage with using these bacterial adhesins is the ability to 
localize the drug at a targeted site of absorption. Increased contact of the drug delivery 
system with the mucosal absorptive membranes of a specific site for an extended period 
could increase the absorption of the therapeutic agent, resulting in a higher drug 
bioavailability. [1-5] We accomplished this previously with a more synthetic functional 
group when we utilized aldehyde-modified PEG tethers incorporated into a pH sensitive 
hydrogel. We envision being able to have similar success utilizing a more biological 
route with a specific bacterium. 
Lactobacillus acidophilus is a probiotic that is part of the bacterial microbiota of 
the gastrointestinal tract of many humans and animals. It has been used in supplements 
and milk products and has had its genome sequence studied extensively for use in various 
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medicinal purposes. [12-14] From these studies, one sequence of protein called surface 
layer protein A (SlpA) has been discovered to be of vital importance in L. acidophilus’s 
ability to adhere and colonize human tissue. While the mechanism of attachment is still 
not fully understood, this sequence has been found to be adhesive to mucus, epithelial 
cells, and also parts of the extracellular matrix such as fibronectin. [12-16] The adhesive 
properties and the nonpathogenic nature of the bacteria are why this has been selected as 
the bacterium of choice for further testing. We were able to get improved adhesion to the 
mucosa with a synthetic aldehyde moiety, but we should be able to get even more 
selective adhesion using more intricate functional groups found throughout nature. The 
bonding of the SlpA adhesin, and that of any of the possible bonding sites of mucin, 
epithelial cells or substances found in the extra cellular matrix, should increase the 
adhesive abilities of the hydrogel yet still be discharged from the body when the mucus 
layer or cells are renewed between six hours to a few days. Much of the research around 
SlpA has been with proving what it can adhere to and how to prevent it. [15, 16] Most 
research revolving around bacterial therapeutics and the lactobacillus strains deal with 
utilizing probiotics or the entire bacterial unit itself to adhere and deliver drugs. [17] 
There has been limited research with bacterial adhesin mediated adhesion for drug 
delivery systems with units such as Type-1 and K-99 fimbriae of E. coli or the invasin of 
Y. pseudotuberculosis but could be problematic due to their toxic nature. [18-21] The use 
of the nonpathogenic SlpA as an adhesive agent opens a new avenue for oral drug 
delivery. 
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A P(MAA-g-EG) pH-sensitive hydrogel was again used as the model drug 
delivery system. Hydrogels with pH-sensitivity make excellent candidates for the oral 
delivery route because of their ability to respond to their environment, they resemble 
natural living tissue, are biocompatible, provide the protection of proteins needed in harsh 
environments, and exhibit high adhesive bond strength in contact with tissues. The latter 
should help to increase residence time even further after preliminary contact by the 
grafted bacterial adhesin. [22-29] An ex vivo testing method referred to as the trough 
method was used in determining adhesion. This method has been used by other 
researchers to determine the adhesive capacity of hydrogel delivery devices when in 
contact with cellular models. [30-32] 
Materials and Methods 
 
Bacterial Purification 
 The Lactobacillus Acidophilus strain NCK1962 was given by Dr. Todd R. 
Klaenhammer from North Carolina State University. Cultures were propagated overnight 
in MRS broth and harvested by centrifugation at 8000 X g for 20 minutes at 4
o
C. The 
pellets were suspended in a 5 M LiCl solution in a 1ml:10mg ratio and stirred for 15 
minutes at 4
o
C. The solution was centrifuged again and the remaining pellet was dialyzed 
for 24 hours in distilled water at 4
o
C using a Spectrapor 6-8000 membrane. A white 
precipitate formed after dialysis and was centrifuged at 40000 X g for 20 minutes at 4
o
C. 
The pellet was resuspended in 1 M LiCl and stirred for 15 minutes at 4
o
C before being 
centrifuged again at 40000 X g for 20 minutes at 4
o
C and washed with 15 ml of cold 
deionized (DI) water. [12] 
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 The purity of the S-layer protein was determined by SDS-polyacrylamide gel 
electrophoresis (PAGE). A western blot and coommassie stain were used. For the western 
blot, the antibody was obtained from Dr. Sandra M. Ruzal from the University de Buenos 
Aires in Argentina.  
Hydrogel Synthesis 
 
The methacrylic acid (MAA) monomer was passed through a dehibit column to 
remove the inhibitor. The polymer films were prepared by free radical UV 
polymerization. The diluted monomer mixture was composed of methacrylic acid (MAA, 
Sigma, St. Louis, MO) and PEGMA with a molecular weight of approximately 500. 
Irgacure® 184 (1-hydroxy-cyclohexyl-phenylketone, Ciba-Geigy, Hawthorne, NY), 
which was used as a photoinitiator, and tetraethylene glycol dimethacrylate (TEGDMA, 
Polysciences Inc. Warrington, PA), which was used as a crosslinking agent was also 
incorporated. Deionized water and ethanol were used as solvents. The monomer solution 
was made in a ratio of 1:1, MAA:EG units, P(MAA-EG) was made with unmodified 
PEGMA. TEGDMA was added as 1 mol% of the total monomer and Irgacure® 184 
added as 1 wt% of the total monomer.  
The monomer solution was dissolved with a 50:50 monomer to solvent weight 
ratio. The total solvent weight was composed of equal parts deionized water and ethanol. 
Once all components were added to the monomer mixture, the solution was sonicated 
until all materials were dissolved into solution. The mixture was purged with nitrogen for 
20 minutes to remove oxygen, which acts as a free radical scavenger. The solution was 
pipetted between two glass slides (75mm X 50mm X 1mm) separated by a 0.8 mm 
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Teflon® spacer. The slides were placed under a UV light (Efos Corporation, Ultracure 
100ss, High pressure mercury lamp, Mississauga, Ontario, Canada) and allowed to 
polymerize for 30 minutes.  
After polymerization was complete, the thin films were washed with deionized 
water daily for one to two weeks to remove all unreacted components. After washing, the 
films were dried under a vacuum (Heraeus VTR-5036, Heraeus Instruments GmbH., 
Hanau, Germany) for 2 days at approximately 30° C. Hydrogel films were crushed and 
sieved with a mesh size of 45µm. Images of particles were taken on a light microscope 
and processed using an image processing program. Particle size distribution was found to 
be 8.5 mm with a standard deviation of 5.8mm. 
The SlpA protein was covalently attached to the hydrogel instead of attached via 
PEG. This attachment occurred through a linkage between the carboxylic acid of the 
methacrylic acid units and the amine groups found on the bacterial protein. [33] Briefly, 
2.5 ml of a 1mg/ml solution of the protein was treated with 200ml of a 200mg/ml 
solution of 4-(4,6-dimethoxy[1,3,5]triazin-2-yl)-4-methylmorpholinium chloride 
(DMTMM, Sigma Aldrich, St. Louis, MO) in distilled water. The solution was placed on 
a rotator for 40-60 minutes at room temperature. The mixture was added to Sephadex G-
25M PD10 columns and eluted after centrifuging. This separated the DMTMM modified 
protein from free DMTMM. The modified protein was added to microparticles of 
P(MAA-EG) hydrogel previously made. The solution was sonicated, vortexed, and 
placed on a rotator overnight at room temperature. The particles were washed twice by 
centrifugation with 1ml of PBS to remove any unbound protein.  SDS-PAGE was used to 
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determine percent protein linked.  A western blot was used with the antibody obtained 
from Dr. Sandra M. Ruzal.  
Swelling Analysis 
 
Dynamic swelling studies were performed using dimethylglutaric acid (DMGA, 
I=0.1M, Acros Organics, NJ) buffers. Ten buffers, with a pH range of 3.2 to 7.6 were 
prepared. The ionic strength of the buffers was controlled with 0.1M sodium chloride 
(NaCl, Sigma Aldrich, St. Louis, MO). Polymer microparticles of P(MAA-EG) were 
compared against the protein linked microparticles by placing 50 mg in 10 mL of the first 
DMGA buffer with a pH of 3.2 for 10 minutes at 37° C. Afterward, the microparticles 
were centrifuged down out of the buffer. The supernatant was poured off and the 
microparticles were weighed to determine the water uptake. The next DMGA buffer of 
the next highest pH was added to the microparticles and the process was repeated up to 
the buffer with a pH of 7.6.  
The following equation was used to determine the weight swelling ratio, Q:  
Q= Wswollen/ Wdry           (1) 
Wswollen and Wdry refer to the weights of the copolymer microparticles in swollen 
and dry states, respectively. These values were then used to plot weight swelling ratio, Q, 
vs. swelling pH. 
Adhesion Analysis 
 
Caco-2 cells were used between 30 and 40 passages. Cells were grown in a 5% 
CO2 atmosphere. All reagents were obtained from Gibco (Gibco-Invitrogen Corp., 
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Carlsbad, CA). Dulbecco’s Modified Eagle Medium (DMEM) was used with 16.7% fetal 
bovine serum (FBS), and 1% each of non essential amino acids and sodium pyruvate. 
Cells were grown in 75 cm
2
 BD Falcon tissue culture treated flasks (Thermo Fisher 
Scientific, Pittsburgh, PA). The medium was replaced every two days and adhesion 
experiments performed every seven days after plating. The cells were grown up to 
confluence, placed on a 45-degree incline and washed with DI water. 30 mg of dry 
particles were dispersed and left for 20 minutes in the incubator. Afterwards, the system 
was flushed with DI water for five minutes at 22ml/min. The detached particles were 
collected, dried and weighed with the adhesive capacity being the percentage of particles 
retained by the tissue. 
Results 
Bacterial Purification Analysis 
 
 SDS-PAGE was performed to determine the purity of the S-layer protein after the 
initial purification process from the bacteria cultures and later after the linking reaction 
with the hydrogel microparticles previously mentioned. A western blot and coommassie 
stain were used to certify the initial purification with subsequent western blots used to 
quantify SlpA linkage to the microparticles. For the western blot, the antibody was 
obtained from Dr. Sandra M. Ruzal from the University de Buenos Aires in Argentina. 
Figure 6.1 shows the western blot stain after initial purification of the L. acidophilus 
strain. A coommassie stain not shown was performed as a secondary check and was 
successful. The bands moving from slot 1 to 7 are different steps in the purification 
process. Slots 1-6 correspond to the following samples taken during the purification 
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process: sample after the 5M LiCl wash; sample of the supernatant after first centrifuge 
step; sample of pellet after first centrifuge step; sample after dilution; sample of 
surpernatant after second centrifuge step; and sample of supernatant after 1M LiCl wash 
and centrifuge step. We can see that bands increase in intensity and thus purity as we 
reach the final purification in the seventh slot. Both figures show a bright solid band at 50 
kDa in the seventh slot which is where we anticipated the purified adhesin being 
according to the literature. [12]  
 After producing more SlpA adhesin, some of the purified samples were used to 
make several standards in DI water ranging in concentration. These standards were used 
with the residual filtrand from the final step to graft the adhesin to the microparticles in a 
western blot assay. This would allow us to quantify the amount of SlpA bound to 
hydrogel microparticles by creating a standards curve of SlpA concentrations to light 
intensity. We were able to accomplish this by gauging the light intensity of the different 
concentrations of the bands in the western blot assay with higher concentrations giving a 
brighter band. Each linking reaction was run to determine the percent SlpA bound of each 
new batch. The reactions produced multiple ranges of percent SlpA bound. These ranges 
were between 30% and 60%. No obvious reason was found for the differences in percent 
SlpA bound as all experiments were performed identically. These particles were then 
used in subsequent swelling and adhesion testing. 
 These studies allow us to confirm that the SlpA protein is successfully purified 
from the L. acidophilus strain and ready for use in the grafting reaction. Secondly, we 
were able to determine the amount of protein attached to the microparticles after going 
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through the reactions steps, giving a yield between 30-60%. This is of note due to the 
difficulty in binding biologics in polymerization and with being one of the first in the 
generation of bacterial improved drug delivery systems. 
Hydrogel Swelling 
 
Dynamic swelling studies were performed to investigate the pH sensitivity and 
water uptake of samples with the SlpA modified hydrogels in comparison to a control 
sample of P(MAA-EG). The phenomenon of complexation occurs through hydrogen 
bonding between electron deficient moieties and moieties containing regions of high 
electron density. This occurs most notably in acidic surroundings because of the 
hydrogen bonding between the ether group of the PEG chain and the carboxylic group of 
the PMAA. [34, 35] As the pH values reach the pKa value of MAA (4.8), the carboxylic 
acids are ionized causing the dissociation of the hydrogen bonds, resulting in a repulsive 
interaction between the PEG chains and the MAA molecules causing what is known as 
decomplexation. Due to the addition of a new moiety, we must determine if the additional 
functional groups present in the amino acids of the SlpA adhesin interferes with the 
interactions between the PEG chains and MAA molecules that result in complexation and 
gives the hydrogels its desirable pH sensitivity. Without this pH sensitivity there would 
be no drug release and thus it is imperative to maintain these characteristics. The highest 
percentage (60%) of linked SlpA was used to show that incorporating the new moiety at a 
high percentage would not adversely affect the swelling and pH characteristics of the 
hydrogel. The dynamic water uptake for each formulation is shown in Figure 6.2. Both 
formulations maintain pH sensitivity with a transition around a pH of 5.6. There was an 
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increase in water uptake as pH increased, indicating that the addition of the SlpA moiety 
does not affect the bonds that cause complexation and decomplexation. Both 
formulations have similar swelling ratios with high points of around 10 and low point of 
around 3.5. The pH transition is similar to the transition seen when hydrogels were cut 
into cylinders and used in dynamic swelling experiments seen earlier in Chapter 4, but 
the overall Q ratio is higher. This difference in Q ratios is easily explained with the 
increase in surface area exposed to the buffer with microparticles leading to more water 
uptake as opposed to compact cylinders.   
This study allows us to confirm several things. First, that the microparticle 
method for dynamic swelling is valid and comparable to the method using cylinders. 
Second and most importantly, the incorporation of SlpA does not affect the desired 
properties of the hydrogel allowing it to maintain its pH sensitivity and not shifting the 
pH transition. Thus, we expect that the new carriers could maintain the same 
characteristics through the oral delivery process. 
Adhesion Analysis 
 
An ex vivo adhesion study utilizing Caco-2 cells also known as the trough method 
was performed to investigate the effectiveness of the bonding of the SlpA protein 
adhesion in aiding cellular adhesion when compared to the interpenetration and 
hydrodynamic forces seen with a control formulation. [30-32] 
During the adhesive experiments, the microparticles were allowed to swell for 20 
minutes in a CO2 rich incubator after being administered to a T-flask of Caco-2 cells that 
had been grown to confluency. Caco-2 is a colonic carcinoma cell line that is commonly 
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used in cell experimentation. The cell line was originally isolated from human 
adenocarcinoma of the colon. These cells express many of the same markers associated 
with normal small intestinal cells and spontaneously differentiate postconfluence to display 
functional apical brush border microvilli and epithelial-cell polarization. The swelling time 
for the microparticles is important since, as stated previously, the initial formation of an 
adhesive bond between a polymer and the biological substrate is the wetting and swelling 
of the polymer. Just 10 minutes of exposure is sufficient to swell the system to conditions 
similar to those in the upper small intestine but 20 minutes was used to stay consistent 
with previously performed experimental procedures in literature.[31, 32] This value 
simulates the physiological situation of a hydrogel traveling through the GI tract to the 
upper small intestine, where it is complexed under the conditions described previously, to 
the target site of adhesion, where it starts swelling and decomplexing.  
The objective was to improve the adhesive performance of a crosslinked 
poly(methacrylic acid) hydrogel, a well-known adhesive polymer, by decorating it with 
SlpA adhesins that allow the L. acidophilus bacterial strain to adhere to cell surfaces. 
First reviewing the properties of the basic P(MAA-EG) hydrogel there is evidence it 
utilizes many secondary chemical interactions from van der Waals interactions, to 
hydrogen bonding which is considered the most important secondary interaction in 
adhesion.[36] When entering the upper small intestine, the secondary forces are 
numerous giving an overall stronger adhesion that would be absent with just one small 
secondary interaction. These forces can hold long enough for swelling and, as a result, 
interdiffusion of the free flowing PEG chains to take place. The PEG chains are not 
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interacting with the poly(methacrylic acid) backbone at the higher pH conditions and are 
able to diffuse through the mucus and enhance adhesion. The SlpA moiety will 
complement these interactions much like the synthetic aldehyde moiety did in the 
previous chapter with the addition of another possibly stronger chemical linkage to 
receptors found on the cell surface throughout the small intestine. 
Figure 6.3 shows the percent retained by the Caco-2 cells for the control hydrogel 
P(MAA-EG) and the 30% bound SlpA modified hydrogel. The lower percent of bound 
SlpA was utilized to show that increased adhesion is possible even with minimal 
amounts. Figure 6.3 shows a percent retained of 70.6% and 82.4% for the P(MAA-EG) 
and SlpA modified hydrogel respectively. The data shows an increase in adhesive 
retention of 16.7% of the SlpA modified hydrogel over that of the control hydrogel. This 
indicates that even in minimal amounts the addition of the added chemical bonding 
through the SlpA protein adhesins causes a greater increase in the adhesion to the cell 
surface than secondary forces and interpenetration alone with possibly even a further 
increase in adhesion possible with the addition of mucin and various extracellular matrix 
proteins that are present throughout the small intestine. The addition of the added 
chemical bonding through the SlpA adhesin causes a greater increase in the adhesion and 
adhesion will only increase with more SlpA due to the availability of more bonding sites. 
Finally, it is important to note that it would be difficult to compare the results 
between the synthetically modified hydrogels that utilize the aldehyde moiety and that of 
the biologically modified hydrogels that utilize the SlpA adhesin since they involve 
different adhesive experiments and different adhesive substrates between mucin solution 
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and Caco-2 cells. Instead we can determine that both successfully upgrade the adhesive 
capacity of the normal control hydrogels of PMAA and P(MAA-EG) with relatively 
small amounts and that both have the ability to improve upon these results making each 
excellent candidates as oral delivery vehicles. However, between the two moieties the 
biological path may hold more potential due to the possibility of multiple adhesive 
pathways along targeted sites and the ability to possibly pinpoint the area of delivery 
unlike the previous synthetic route which binds to any amine in the chime, mucin, and 
cells of the small intestine. 
Overall, this study allowed us to determine the increased adhesion of the SlpA 
modified hydrogels. With increased adhesion over the control formulation, this new 
material could potentially improve drug delivery due to increased residence time in the 
upper GI tract.  
Conclusions 
 
The present work was performed to determine the effectiveness of using chemical 
linkages by utilizing a protein found in an everyday probiotic bacteria, in this case SlpA 
from L. acidophilus, to increase the limited adhesion of the P(MAA-EG) hydrogel. The 
better adherence to the small intestine would lead to increased residence time, release at 
the delivery site, and would presumably affect the bioavailability of the protein. 
Hydrogels with PEG tethers and with varying percentages of SlpA modified hydrogels 
were synthesized and characterized to determine any improved adhesive capacity without 
affecting the overall characteristics of the oral delivery device. Western blot assays 
confirmed the purification of SlpA and percent bound after linking to P(MAA-EG) 
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hydrogel microparticles. Dynamic swelling studies showed that the SlpA functionalized 
hydrogels retained their pH sensitivity at pH of 5.6. A widely accepted ex vivo 
experiment showed an improved adhesive capacity of 16.7% with the increased chemical 
linkages of the SlpA moiety over that of the control formulation. [30-32] These findings 
indicate the potential these biologically functionalized hydrogels have for improved oral 
drug delivery and that they also compare favorably along with the swelling and adhesive 
characteristics of the synthetically modified hydrogels that used an aldehyde functional 
group. 
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 Figure 6.1. Western blot assay of samples taken during purification process of SlpA 
protein from L. acidophilus: Slots 1
during the purification process: (1) sample after the 5M LiCl wash, (2) sample of 
supernatant after first centrifuge step, (3) sample of pellet after first centrifuge step, 
(4) sample after dilution, (5) sample of supernatant after second centrifuge step, (6) 
sample of supernatant after 1M LiCl wash and (7) centrifuge step and final
sample. 
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Figure 6.2. Dynamic swelling results of P(MAA-EG) and SlpA tagged microparticles 
after spending 10 minutes in each pH buffer successively to gauge pH sensitivity. 
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Figure 6.3. Percent of particle retention of P(MAA-EG) and SlpA tagged 
microparticles to seeded Caco-2 cells after DI water wash from the trough adhesive 
method. P value = 0.01. 
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Chapter 7: Conclusions and Recommendations 
 
The field of bioadhesion is rapidly evolving with uses ranging from developing 
more effective drug delivery systems, to preventing and understanding disease 
transmission. One approach of great interest involves using bioadhesive materials in 
contact with mucosal surfaces (mucoadhesion) and cellular surfaces (celluar adhesion), to 
improve the efficacy of therapeutic treatments. While the understanding of adhesion 
needs further research the benefits gained by using adhesive biomaterials in the design of 
new drug delivery systems are essential to the efficacy of this area of research. There are 
several advantages that adhesive drug release devices bring to the controlled release field, 
but the main one is the ability to maintain the delivery device at a specific location in the 
body for an extended period of time. These features are able to provide higher efficiency 
of local and systemic therapies, resulting in a higher bioavailability of the drug in the 
body. 
The novel functionalization of pH responsive hydrogels were evaluated in this 
work to understand their application in bioadhesive controlled release drug delivery 
systems. The present work was performed to determine the effectiveness of using 
synthetic and biological linkages in improving and understanding adhesion of the drug 
delivery vehicle. In the first part of this thesis, a synthetic aldehyde moiety was used, to 
increase the limited adhesion of the hydrogel. The better adherence to the small intestine 
would lead to increased residence time, release at the delivery site, and would 
presumably affect the bioavailability of the protein. Aldehyde was functionalized onto 
PEG tethers by catalytic reaction with TPAP and grafted onto hydrogels in varying 
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percentages. Swelling studies showed that the aldehyde functionalized hydrogels retained 
their pH sensitivity while release studies showed that the addition of the aldehyde moiety 
did not hinder the insulin release seen in previous work with nonfunctionalized 
hydrogels. Widely accepted in vitro tensile testing showed improved adhesive capacity 
with increased chemical linkages with the aldehyde moiety in both dry and wet 
conditions.  
In the second part of this thesis, a novel in vitro adhesive testing method was 
generated.  AFM force modulation was used as an effective model for in vitro adhesion 
testing of drug delivery vehicles specifically pH sensitive hydrogels on a molecular level. 
Utilizing a more accurate in vitro method would bring new insight into the methods of 
adhesion and further the work of improving oral drug delivery vehicles. Hydrogels with 
and without PEG tethers and with aldehyde modified PEG tethers were used in this study 
and compared with work previously done using the Instron tensile testing method. 
Microparticle tagged AFM tips were made, confirmed for use in experimentation and 
showed an overall increase of adhesion across all formulations when compared with bulk 
testing. Preswollen AFM data was utilized to determine that the aldehyde moiety alone 
shows an increase of adhesion without the addition of secondary or interpenetrative 
forces. Overall, a new method of in vitro testing for adhesive capabilities was established. 
The third part of this thesis was performed to determine the effectiveness of using 
biological linkages by utilizing a protein found in an everyday probiotic bacteria, in this 
case SlpA from L. acidophilus, to increase the limited muco and cellular adhesion of the 
P(MAA-EG) hydrogel. Hydrogels with PEG tethers and with varying percentages of 
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SlpA modified hydrogels were synthesized and characterized to determine any improved 
adhesive capacity without affecting the overall characteristics of the oral delivery device. 
Western blot assays confirmed the purification of SlpA and percent bound after linking to 
P(MAA-EG) hydrogel microparticles. Dynamic swelling studies showed that the SlpA 
functionalized hydrogels retained their pH sensitivity and a widely accepted ex vivo 
experiment utilizing Caco-2 cells showed an improved adhesive capacity with the 
increased chemical linkages of the SlpA moiety. 
To summarize the work contributed to the understanding of the drug delivery 
systems capable of modulating adhesion. Both the synthetic and biological modified 
hydrogels were shown to be effective in maintaining the pH responsive nature of the 
systems and increasing the overall muco and cellular adhesion respectively. Also, the 
capabilities of AFM force modulation as a novel in vitro tool was explored and found to 
accurately determine the adhesive capabilities of drug delivery vehicles on a molecular 
level. Future recommendations would involve developing a sanitary setup for Caco-2 
covered slips to be used in AFM force modulation testing to explore SlpA modified 
hydrogels. Furthermore, further research involving other biologically based adhesive 
properties should be considered especially those with properties that affect transport 
across the epithelia. 
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